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Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 6 
lncRNA    long-noncoding RNA 
MAO-A   Monoamine Oxidase A 
MDD    Major Depressive Disorder or Major Depression 
MeDIP-chip   Methylated DNA immunoprecipitation coupled with array 
hybridization 
miRNA   micro RNA 
mRNA   messenger RNA 
N    Number 
N-terminal   Amine-terminus, start of a protein 
NGFI-A   Nerve growth factor-induced protein A 
Nr3c1    Nuclear receptor subfamily 3, group C, member 1,  
Gene name fort the GR 
p    p-value 
piRNA   piwi interacting RNA 
PPI    peptidylprolylisomerase (PPI) domain 
PTSD    Post-Traumatic Stress Disorder 
RNA    Ribonucleic acid 
rs     Reference SNP cluster ID. 
SLC6A4  Solute carrier family 6 (gene name for serotonin 
transporter) 
SNP    Single Nucleotide Polymorphism 
TALEs    Transcription activator-like effectors 
TATA-box    cis regulatory DNA sequence, often found in promoters 
TBP    TATA-binding protein 
TPR     tetratricopeptide repeat protein domain 
TSS    Transcription start site 
 
 
 
 
Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 7 
List of Figures 
 
Figure Title Page 
Figure 1.  Manhattan plot of the most recent GWAS on schizophrenia. 18 
Figure 2.  
Manhattan plot similar to Figure 1 representing genome 
wide significant association of genetic variants with MDD. 
19 
Figure 3.  
Interaction of FKBP5 with exposure to childhood abuse on 
risk for PTSD in adulthood. 
23 
Figure 4.  FKBP51 interaction with the GR complex. 24 
Figure 5.  
Replication and extension of previous GxE of FKBP5 with 
childhood abuse on PTSD diagnosis in N=519. 
80 
Figure 6.  
Chromatin conformation capture (3C) of FKBP5 shows the 
interaction of intronic downstream regulatory elements with 
the transcription start site (TSS). 
82 
Figure 7.  Genotype-dependent demethylation in intron 7 of FKBP5. 83 
Figure 8.  
Demethylation of FKBP5 intron 7 in a human hippocampal 
progenitor cell line. 
84 
Figure 9.  
Demethylation of FKBP5 intron 7 leads to enhanced GR 
activation and GR resistance. 
86 
Figure 10.  
Heat map of gene expression profiles between PTSD cases 
with childhood abuse and adult trauma vs. trauma exposed 
controls (left) and PTSD cases with adult trauma only vs. 
trauma exposed controls (right). 
88 
Figure 11.  
DNA methylation changes may contribute more in PTSD in 
response to childhood abuse than in PTSD in response to 
adult trauma. 
89 
 
 
 
Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 8 
List of Tables 
 
Table  Title Page 
Table 1. Examples for candidate gene and genome-wide studies on 
DNA methylation on stress-related psychiatric disorders and 
early life trauma in humans. 
32-34 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 9 
List of Publications  
 
The work presented in this cumulative thesis was conducted under 
supervision and mentorship of Elisabeth B. Binder MD, PhD at the 
Department for Translational Research in Psychiatry at the Max Planck 
Institute for Psychiatry in Munich, Germany. The thesis presented here 
contains the following publications: 
 
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace 
TWW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, 
Ressler KJ, Rein T, Binder EB. Allele–specific DNA FKBP5 demethylation: a 
molecular mediator of gene–childhood trauma interactions. Nature Neuroscience. 
16(1), 33-41, 2013 doi:10.1038/nn.3275.  
 
Mehta D, Klengel T, Conneely KN, Smith AK, Rex-Haffner M, Loeschner A, Gonik M, 
Mercer KB, Bradley B, Müller-Myhsok B, Ressler KJ, Binder EB. Childhood 
maltreatment is associated with distinct genomic and epigenetic profiles in 
posttraumatic stress disorder. Proc. Natl. Acad. Sci. USA. 110(20), 8302-8307, 2013 
doi: 10.1073/pnas.1217750110 
 	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 10 
Declaration/Declaration of contribution as co-author  
 
Paper I 
   
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace 
TWW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, 
Ressler KJ, Rein T, Binder EB. Allele–specific DNA FKBP5 demethylation: a 
molecular mediator of gene–childhood trauma interactions. Nature Neuroscience. 
16(1), 33-41, 2013 doi:10.1038/nn.3275.  
 
T.K. and E.B.B. designed the experiments, performed the luciferase assays and the genetic, 
methylation and expression analyses, analyzed the data, and wrote the initial version of the paper. 
D.M. performed the RNA expression experiments and data analyses and revised the paper. M.R.-H. 
performed the chromatin conformation capture experiments. C.A. and C.M.P. performed the cell-
culture experiments with human hippocampal progenitor cells and revised the paper. T.W.W.P. 
performed ex vivo glucocorticoid receptor sensitivity experiments and revised the paper. J.C.P. 
analyzed magnetic resonance imaging data and revised the paper. E.B.B., F.H., K.J.R., K.B.M., 
H.S.M., B.B., C.B.N., C.M.H. and T.R. organized sample collection and collaborations, obtained 
funding, supervised data analyses, and revised the paper. 
 
Paper II  
 
Mehta D, Klengel T, Conneely KN, Smith AK, Rex-Haffner M, Loeschner A, Gonik M, 
Mercer KB, Bradley B, Müller-Myhsok B, Ressler KJ, Binder EB. Childhood 
maltreatment is associated with distinct genomic and epigenetic profiles in 
posttraumatic stress disorder. Proc. Natl. Acad. Sci. USA. 110(20), 8302-8307, 2013 
doi: 10.1073/pnas.1217750110 
 
T.K. extracted DNA for methylation arrays, measured and controlled quality. TK implemented 450k 
methylation array procedures and hybridized 450k methylation arrays as well as designed Sequenom 
EpiTYPER validation experiments and revised the paper. 
 
 
 
 
 
 
 
 
 
Torsten Klengel          Elisabeth B Binder 
 
 
 
 
Epigenetic Signature of Childhood Abuse                                           Torsten Klengel 
 11 
English Summary 
 
Childhood abuse is one of the major risk factors for the development of adult 
psychopathology though the response to childhood abuse and other types of early 
life adversities is not uniform. Genetic predisposition modulates the exposure to 
environmental factors in form of gene by environment interaction. This has been 
shown for FKBP5, a modulator of the stress hormone axis, with certain alleles in 
FKBP5 conferring a higher risk towards PTSD in adulthood in response to childhood 
abuse. This thesis investigates the potential molecular mechanism behind this gene 
by environment interaction and delineates an allele-specific demethylation 
mechanism in response to childhood abuse. In addition, data on genome-wide gene 
expression and DNA methylation profiles in peripheral blood in response to 
childhood abuse is presented providing evidence for the hypothesis that childhood 
trauma leads to a different molecular trajectory towards adult psychopathology 
compared to adult traumatization. The data presented here contribute to our 
understanding of the molecular mechanisms underlying gene by environment 
interactions in psychiatry and the pathophysiology of trauma- and stress-induced 
psychiatric disorders. 
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Deutsche Zusammenfassung 
 
Missbrauch und Misshandlung im Kindesalter ist einer der stärksten Risikofaktoren 
für psychiatrische Erkrankungen im Erwachsenenalter. Jedoch entwickelt nur ein Teil 
der exponierten Kinder im Erwachsenenalter eine psychiatrische Erkrankung. Dabei 
moduliert die individuelle Genetik das Verhältnis von Umweltfaktoren und späteren 
Erkrankungen in Form von Gen-Umwelt-Interaktionen. Ein Beispiel dafür ist die Gen-
Umwelt-Interaktion von FKBP5, einem Regler der Stress-Hormon-Achse, und 
Traumatisierung im Kindesalter auf das Risiko an einer post-traumatischen 
Belastungsstörung im Erwachsenenalter zu erkranken. Sogenannte Risikoallele in 
Form von Einzelnukleotid-Polymorphismen in FKBP5 erhöhen dabei die 
Wahrscheinlichkeit, an einer PTBS im Erwachsenenalter zu erkranken. Die 
vorliegende Arbeit untersucht die zu Grunde liegenden molekularen Mechanismen 
dieser Gen-Umweltinteraktion und zeigt, dass Kindesmissbrauch und Misshandlung 
eine lang-anhaltende epigenetische Veränderung im FKBP5 Gen in Abhängigkeit 
von der genetischen Prädisposition bewirkt. Darüber hinaus zeigen genom-weite 
Genexpression und DNA Methylierungsprofile aus peripherem Blut eine spezifische 
molekulare Antwort auf Kindesmissbrauch und Kindesmisshandlung und stützen 
damit die Hypothese, dass Traumatisierungen im Kindesalter zu einer von 
Traumatisierung im Erwachsenenalter unterscheidbaren molekularen Antwort führen.  
Die vorliegende Arbeit zeigt damit erstmals einen Mechanismus für eine Gen-
Umweltinteraktion in der Psychiatrie und führt Genetik und Umweltfaktoren als 
bestimmende Risikofaktoren in einem molekularen Modell zusammen. Darüber 
hinaus stützen die präsentierten Daten die These, dass Traumatisierung im 
Kindesalter im Gegensatz zu Traumata im Erwachsenalter zu unterscheidbaren 
molekularen Veränderungen führt, die einerseits eine individualisierte Diagnostik 
zulassen und auf der anderen Seite therapeutische Möglichkeiten eröffnen die auf 
die individuelle Krankheitsgeschichte Rücksicht nehmen und so die 
Erfolgswahrscheinlichkeit einer Therapie erhöhen. 
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Aims of the thesis 
 
The first goal of this thesis is to investigate the molecular mechanisms underlying the 
statistical gene by environment interaction (GxE) of FKBP5 with childhood abuse on 
the risk to develop psychiatric disorders, in particular post-traumatic stress disorder 
(PTSD) in adulthood. Therefore, the molecular function of the single nucleotide 
polymorphism (SNP) rs1360780, an intronic variant that has been described in 
multiple GxE and gene association studies, will be investigated. In addition, this 
thesis will investigate the molecular response to childhood abuse in humans on the 
level of DNA methylation as one major epigenetic factor and if this response is 
genotype dependent. This thesis will also test the hypothesis that peripheral tissue 
such as whole blood may be informative for the detection of environmentally 
induced epigenetic alterations and mechanisms which may also overlap with 
alterations in neuronal tissue, potentially contributing to psychiatric disorders. The 
second part of this thesis will investigate the genome wide gene expression and 
DNA methylation profile of childhood abuse in humans. Therefore, adult-trauma 
exposed, PTSD positive individuals with and without the history of childhood abuse 
will be compared to adult-trauma exposed PTSD negative individuals and 
differences in the gene expression and DNA methylation profile are presented.  
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Introduction  
 
Stress-Related Psychiatric Disorders – Major Depression and Post-Traumatic Stress 
Disorder as Examples 
 
Psychiatric disorders such as major depression (MDD) or post-traumatic stress 
disorder (PTSD) are highly prevalent in the general population with an estimated 
lifetime prevalence for MDD of 17.1% (12.7% for males and 21.3% for females) 1 and 
a lifetime prevalence for PTSD of 7.8% (5.0% for males and 10.4% for females) 2 with 
considerable variations in prevalence depending on geographic location, ethnicity, 
gender, socioeconomic status and other factors. For MDD, the burden of disease as 
measured by disability adjusted life years (DALYs) was estimated to account for 2.5% 
of the global DALYs and therefore identified as the leading cause of burden 
worldwide 3.  
 
Despite considerable efforts to delineate the underlying pathomechanisms during 
the last decades, our understanding of the molecular mechanisms underlying 
multifactorial and complex disorders such as schizophrenia, MDD and PTSD remain 
elusive and currently available treatment options are often ineffective leading to 
prolonged treatment and often chronic illness.  
 
Pathophysiology – Genetics 
 
Twin, family and more recently genetic association studies support the notion that 
genetic factors contribute to the risk of developing psychiatric disorders. In contrast 
to monogenic diseases, psychiatric disorders are predominantly complex disorders 
most likely with multiple interacting genetic variations contributing to the 
phenotype. The heritability for MDD, i.e. the proportion of variance in MDD risk 
attributed to genetic factors, has been estimated to be 37% and between 30% and 
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40% for PTSD indicating a moderate contribution of genetic factors to the disease 4-
6. Numerous candidate gene association studies have been performed in the past 
decades indicating associations between specific genetic variation, most often 
represented by common single nucleotide polymorphisms (SNPs), and disease 
phenotypes. Although these studies helped gain more insight into the genetic 
liability to disease risk, many candidate association studies failed replication or 
showed only minimal contribution to disease risk. More recently, genome wide 
association studies (GWAS) have been performed for several psychiatric disorders. 
These studies represent an unbiased approach towards identification of genetic 
variants associated with specific traits on a genome wide level but require large 
sample sizes to comply with statistical testing needs especially in the field of 
psychiatry where effect sizes are small. To date, the largest GWAS performed 
collected genetic data of about 40,000 schizophrenia cases and over 113,000 
controls yielding over 100 distinct genetic loci potentially contributing to the risk to 
develop schizophrenia (Figure 1) 7. 
 
Figure 1. Manhattan plot of the most recent GWAS on schizophrenia. The red line represents the 
statistical threshold of p=5×10-8 for genome wide significance. In total 108 loci were found to be 
associated with schizophrenia suggesting genes i.e. involved in immune function but also unrelated 
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to previous findings to influence the genetic disposition to develop schizophrenia. Figure taken from 
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Nature, 2014 7.  
 
This most successful study so far supports the ability to detect genetic variants that 
contribute –even marginally- to the risk for disease by increasing the overall N in 
psychiatric GWAS. In contrast, GWAS on MDD or PTSD have so far not yielded 
robust genome-wide significant results 8-14. The most current GWAS on MDD 
comprises about 10,000 cases and 10,000 controls but failed to detect a genome 
wide significant signal at a sample size at which previous schizophrenia GWAS 
already detected 5 significant signals (Figure 2).  
 
Figure 2. Manhattan plot similar to Figure 1 representing genome wide significant association of 
genetic variants with MDD. No SNP reached genome wide significance investigating 9240 cases vs. 
9519 controls. Figure taken from Major Depressive Disorder Working Group of the Psychiatric GWAS, 
Mol. Psychiatry, 2012 8. 
 
For PTSD, the current GWAS’ performed were considerably limited in their sample 
size and also failed to detect a robust genome wide significant signal 12-14. For both 
entities, MDD and PTSD, large collaborative efforts led by the Psychiatric Genomics 
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Consortium are underway to collect more data leading to larger overall sample sizes 
8. 
 
Although the schizophrenia studies showed that increasing the overall sample size is 
a justified strategy, disorders with lower genetic contribution or higher genetic 
heterogeneity such as MDD and PTSD might require samples sizes that are 
unfeasible to achieve. Moreover, although worldwide collaborative efforts can 
collect an enormous amount of genetic and phenotypic data, an independent 
replication of such huge efforts is difficult to achieve. In addition, MDD and PTSD 
exhibit in contrast to schizophrenia not only a stronger genetic heterogeneity but 
also a much stronger phenotypic heterogeneity with potentially very distinct 
disorders combined under the clinical terms MDD and PTSD thus making the 
identification of robust genetic signals challenging. Finally, in contrast to 
schizophrenia, environmental factors contributing to the overall risk for disease are 
thought to be more pronounced in MDD and PTSD 15-20.   
 
Pathophysiology – Environmental factors 
 
The strong influence of negative environmental factors on the development of MDD 
has been shown for childhood abuse and stress exposure through so-called life 
events, highlighting the profound influence of the environment on disease risk 21-23. 
Moreover, PTSD is regarded as the prototype disorder with respect to 
environmental impact illustrating the influence of the environment through the 
exposure to a qualifying trauma being necessary to trigger the disease 15. Moreover, 
numerous studies employing animal models showed the profound effect of 
environmental stressors in particular in early life on behavioral and molecular 
phenotypes 24,25. Nevertheless while most humans are exposed to stressful or even 
traumatic life events during their life time, only a minority of the affected individuals 
develop any disease. This leads to the concept of gene by environment interaction 
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(GxE) combining the effects of genetic predisposition and environmental factors 26. 
In fact, GxE refers to the differential effect of a given environment on a phenotype 
depending on the individual’s genotype. Although current research often focuses on 
negative life events, trauma and severe stress, the presence of positive 
environmental conditions such a supportive social network or an adequate 
socioeconomic status also influences mental health status. Thus, by definition, GxE 
studies should take positive environments into account potentially counterbalancing 
the impact of trauma exposure 27. Finally, the exposure to stress does not form a 
linear relationship with negative mental health outcome but might also increase 
resilience depending on timing, duration and intensity of the stressor and 
subsequent environmental conditions 28. 
 
Gene by Environment Interactions (GxE) 
  
Although the first theoretical and experimental principles of GxE have been 
described since the early last century, groundbreaking studies by Avshalom Caspi 
and Terrie Moffitt first combined the influence of the environment and the influence 
of genetic factors towards stress-related disorders in a statistical framework of GxE. 
They described the interactive effects of genetic predisposition at the monoamine 
oxidase A (MAO-A) locus and the serotonin transporter locus (SLC6A4) with 
childhood adversities in human towards the risk to develop antisocial behavior and 
depression 29,30. Thus, for the first time the authors showed that the influence of the 
environment represented by childhood maltreatment is not uniform towards the 
development of psychiatric disorders but moderated by the genetic disposition with 
so called risk alleles leading to a higher risk of disease compared to so called 
protective alleles associated with no or a reduced risk in response to maltreatment 
exposure. These results triggered subsequent studies showing that environmental 
factors differentially influence GxE depending on the type of environmental factor, 
moderating factors such as social context, timing of the trauma or environmental 
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factor, severity and how they are measured. Further studies investigated other 
candidate loci from the monoamine transmitter system, neurotropic factors and the 
hypothalamus-pituitary adrenal axis that were associated with stress-related 
phenotypes 31. No genome-wide GxE studies have been published so far.  
 
Although these studies highlighted the importance of the interaction of environment 
and genetic predispositions, criticism has been raised because of low sample sizes 
leading to a lack of power, tendency to yield false positive results and low 
replication rates 26,31-33. In addition, the statistical framework of GxE studies has been 
challenged because of the lack of proper control over confounding factors such as 
gender, ethnicity and age 34. A critical factor is the measurement of the environment 
varying from prospective third party records such as governmental records to 
retrospective self-reports by affected individuals and from very distinct 
environmental factors such as childhood sexual abuse to broader inventories such as 
stressful life events. In addition, the environment is a complex, multidimensional 
space with many environmental factors mutually influencing each other and specific 
GxEs. The GxE of the 5-HTTLPR and the exposure to a natural disaster on the risk to 
develop PTSD highlights this notion as the interaction was observable only in 
hurricane exposed individuals living in areas with a low socioeconomic status 
compared to exposed individuals living in a more advantageous context 35,36.  
 
Besides the conceptual and statistical considerations mentioned above, knowledge 
about the molecular underpinnings of the statistical findings might provide a better 
understanding of GxE and of the pathophysiology of mental disorders.   
 
FKBP5 influences the regulation of the hypothalamus-pituitary-adrenal axis 
 
A prominent example of subsequent GxE studies is the interaction of the FKBP5 
(FK506 binding protein 5) gene with childhood abuse on the risk for PTSD, 
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depression, suicidal behavior and aggression 37-42. In humans, FKBP5 functions as a 
regulator of the glucocorticoid receptor (GR) and the hypothalamus-pituitary-adrenal 
(HPA) axis. FKBP5 is involved in the regulation of this central stress hormone axis by 
negative feedback loops, which are critical for cortisol secretion. The dysregulation 
of the HPA axis and its feedback loops has been implicated in the pathophysiology 
of many stress-related psychiatric disorders 43. First shown by Binder et al., 
childhood abuse exposure lead to higher PTSD symptom levels in adulthood in 
individuals carrying a risk haplotype of FKBP5 including the SNPs rs3800373, 
rs9296158, rs9470080 and rs1360780 compared to individuals carrying the 
protective haplotype 37. Of note, although this interaction appeared robust, no 
interaction of any SNP in FKBP5 with adult trauma on adult psychopathology was 
observed (Figure 3). This GxE was later replicated 38 and further studies suggested 
that FKBP5 SNPs interact with childhood abuse not only on PTSD but also on the 
risk to develop MDD, aggressive behavior, suicidal ideation, general health and 
intermediate phenotypes such as amygdala reactivity 44.  
 
Figure 3. Interaction of FKBP5 with exposure to childhood abuse on risk for PTSD in adulthood. The 
left panel shows that increasing exposure to severe childhood abuse lead to an increasing severity of 
PTSD symptoms in childhood. This relationship is moderated by FKBP5 with the “risk” allele leading 
to higher symptom levels in adulthood compared to the “protective” allele. In contrast, the right 
panel shows the relationship of exposure to adult trauma and PTSD symptom severity, which is not 
moderated by genetic variation in FKBP5. Figure adapted from Binder et al., 2008 37. 
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FKBP5 as a molecular hub for gene by environment interactions 
 
FKBP51 (gene name FKBP5, located on the short arm of chromosome 6) was 
discovered in 1985 as part of the steroid hormone receptor complex 45. The name 
FKBP5 or FKBP51 is derived from the ability of FKBP51 to bind FK506 (Tacrolimus), 
an immunosuppressive drug that inhibits the peptidylprolylisomerase (PPI) domain 
46. Apart from the PPI domain, FKBP5 also contains a binding domain (TPR – 
tetratricopeptide repeat protein domain) for Heat shock protein 90 (Hsp90), a 
chaperone protein 47. Studies in Squirrel monkeys showed that although these 
animals exhibited high levels of cortisol, they did not develop signs of 
hypercortisolaemia as expected 48. The underlying mechanism for this discrepancy 
was identified later showing that the glucocorticoid receptor (GR) of squirrel 
monkeys has a low affinity for cortisol without exhibiting causative sequence 
differences 49. Moreover, subsequent studies showed that squirrel monkeys have 
high levels of FKBP51 that were shown to result in inhibitory effects on GR function 
leading to GR resistance 50-53. FKBP51 reduces the affinity of the GR to the activating 
hormone cortisol thereby reducing the translocation of the GR to the nucleus and 
inhibiting the transcriptional activation and repression of GR dependent genes 53. It 
has been speculated that the inhibitory effect of FKBP51 is mediated by replacing 
other proteins from the GR-complex such as the homologue FKBP52 that interacts 
with the dynein/dynactin motor complex and facilitates the translocation of the GR 
into the nucleus 53-56 (Figure 4).  
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Figure 4. FKBP51 interaction with the GR complex. FKBP5 is transcriptionally activated by the GR 
through binding to predominantly intronic GREs leading to an increased FKBP51 protein translation. 
FKBP51 then provides a negative feedback to the GR through binding via hsp90 thus lowering the 
affinity of cortisol to the GR. Cortisol binding to the GR leads to an exchange of FKBP51 with FKBP52 
(transcribed from the FKBP4 gene) allowing the translocation of the GR to the nucleus. Figure taken 
from Binder, PNEC, 2008 57. 
 
FKBP51 as part of the negative feedback loop limiting the sensitivity of the GR to 
cortisol is transcriptionally activated by the GR itself through binding of the GR to 
several functional glucocorticoid response elements (GREs) located in the promoter 
region but also in downstream intronic regions that might form a three-dimensional 
loop structure to establish contact between the downstream enhancer elements and 
the promoter region 58,59. Dynamic FKBP5 expression is present in many tissues 
including peripheral tissues such as whole blood and saliva but is also present in the 
human central nervous system and strong expression is observed at baseline in the 
rodent hippocampus as well as after transcriptional induction in the amygdala and 
the paraventricular nucleus 60-64. 
 
The ability of the GR to transcriptionally activate the FKBP5 gene and the ability of 
FKBP5 as a protein to regulate GR function suggested that mRNA/protein 
expression levels could be used as a marker for GR sensitivity. Although this 
consideration is valid, high FKBP5 levels could in fact represent a highly active GR 
(thereby activating FKBP5) or a less active GR (through inhibition by FKBP5), a 
problem that can be solved by analyzing stimulated expression data, for example 
before and after GR activation by a synthetic agonist representing a sensitive 
readout of the GR status 61,65.  
Based on the role of FKBP5 in regulating the HPA axis, an early candidate gene 
association study of FKBP5 on antidepressant treatment response in depressed 
individuals showed FKBP5 SNPs were associated with HPA axis responsiveness as 
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well as to antidepressant treatment response 66. Additional studies linked ‘risk’ 
FKBP5 polymorphisms with the delayed recovery from psychosocial stress in healthy 
individuals 67, increased salivary cortisol release in infants in response to mild stress 
68, non-suppression of the stress hormone axis in response to dexamethasone 
administration 37 and activation of stress-related brain regions 69. In clinical cohorts, 
the association of ‘risk’ haplotypes or polymorphisms is less straightforward with risk 
allele carriers showing GR resistance through dexamethasone suppression and a 
reduced FKBP5 mRNA induction in MDD 61,70 but enhanced GR sensitivity in PTSD 
37,71. 
 
The SNPs previously implicated in gene association and GxE studies mentioned 
above are in high linkage disequilibrium and distributed across the locus from the 
promoter area to the 3’UTR in Caucasians and intron 1 to the 3’UTR in Africans thus 
making the identification of a causal variant difficult. 
 
Epigenetic Modifications and Gene Regulation 
 
Epigenetics or epigenetic modifications subsume molecular modifications and 
mechanisms of chromatin organization and gene regulation that act without 
changing the underlying DNA sequence. In a strict definition, these changes are 
stably inherited through either mitosis and/or meiosis, although many current 
examples of epigenetic mechanisms do not fulfill this requirement. This has lead to a 
broad definition of epigenetics that includes mechanisms of gene regulation without 
alterations of the genetic code. Epigenetics initially focused on the question of how 
diverse cellular phenotypes can arise from a singular genotype blueprint, i.e. how 
cell lineage identity is achieved and maintained by non-genetic factors and only 
more recently has the term epigenetics been adopted to describe non-genetic 
mechanisms influencing a phenotype.  
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Epigenetic mechanisms include the post-translational modification of histone 
proteins, modifications of single nucleotides most commonly in form of DNA 
methylation or hydroxymethylation at cytosine residues altering the chromatin 
structure and the accessibility of the DNA to transcriptional regulators and the 
regulation of transcription and translation by non-coding RNAs. For a 
comprehensive description of these epigenetic mechanisms, see 72-78. Here, I only 
briefly summarize the main features of these modifications. 
 
Histone-modification: The DNA strand needs to be highly condensed into 
chromosomes, which is facilitated by wrapping the DNA around core histone 
proteins forming the nucleosome and thereby allowing the DNA to fit into the 
nucleus. To regulate the accessibility of important functional regions of the DNA 
strand to transcriptional regulators, histone proteins can comprise a plethora of 
modifications predominantly at the N-terminal tails that alter the spatial structure of 
the chromatin and the interaction of DNA binding proteins leading to an increase or 
decrease of transcription.  
DNA methylation and related chemical modifications: DNA methylation is the 
addition of a methyl group to nucleotide residues, where cytosine is the most 
common. These modifications influence how proteins bind to the DNA leading to 
increased or decreased transcription depending on their genomic location. More 
recent work shows that there are modifications beyond the classical 5-methyl 
cytosine modification with 5-hydroxymethyl cytosine as potentially important 
modification in neuronal tissue 79. The major determinant of DNA methylation 
patterns is the nucleotide sequences itself i.e. though the distribution of GC content 
and CpG density but also repetitive elements and transcription factor binding sites. 
Additional evidence has been shown for a genetic determination of DNA 
methylation pattern by DNA sequence and sequence variants 80.  
Non-coding RNAs: Aside from protein coding RNAs, non-coding RNAs play a 
major role in the regulation of gene transcription 81,82. Non-coding RNAs include i.e. 
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micro RNAs (miRNAs), piwi-interacting RNAs (piRNAs) or long non-coding RNAs 
(lncRNAs) that can interfere with transcriptional regulation and translation on 
multiple levels.  
 
For a long time, epigenetic modifications, especially DNA methylation, have been 
considered irreversible defining cellular identity in a multicellular organism. By now it 
has been shown that even stable chemical modifications such as DNA methylation 
can show a highly dynamic regulation with the potential of reversibility making these 
mechanisms suitable for encoding the long-term impact of the environment also in 
post-mitotic tissue such as neurons. Although depicted here separately for clarity, 
epigenetic mechanisms form a complex interactive network with joint activities of 
different mechanisms contributing to a molecular outcome 83. The epigenetic state 
comprising all epigenetic mechanisms within the cell is called the epigenome and 
varies from cell to cell. Epigenetic mechanisms and epigenetic modifications are 
associated with a broad range of medical conditions spanning all fields of medicine 
from cancer, metabolic disorders to neurological and psychiatric disorders. Due to 
the availability of cost-effective methods that allow the high-throughput 
investigation of methylation marks, DNA methylation became the best-investigated 
epigenetic mark in psychiatry especially in human cohorts. Therefore I will focus on 
DNA methylation in the next chapters not excluding the contribution of other 
epigenetic mechanisms towards stress-related psychiatric disorders. 
 
Environmental Epigenetics  - Focus on Stress and Behavior 
 
Epigenetic mechanisms as described above shape genomic architecture and 
function inside the nucleus and are considered as a molecular bridge between the 
genome and the surrounding environment. Thus, epigenetics are thought to be able 
to facilitate the interaction and adaptation of the organism to varying environmental 
conditions. This concept raised great interest in many biomedical fields including 
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psychiatry and neuroscience 84-87. Moreover, it has been shown that the many 
epigenetic marks remain plastic i.e. changeable in post-mitotic neuronal tissue 
throughout the lifespan and that epigenetic drugs such as HDAC inhibitors exert 
behavioral effects in animal models fueling the hope of epigenetic drugs potentially 
influencing psychiatric or neurological disorders 88-90.  
 
Epigenetic studies, in particular with regard to stress-related disorders, have focused 
on the HPA axis as the most important stress response system in mammals and the 
first studies in animal models support the hypothesis of a differential influence of the 
environment on the epigenome especially in HPA related genes. In addition, most 
of the studies focused on DNA methylation, in part due to the availability of cost 
effective and readily available analytical methods. One of the most influential 
examples is the nurturing behavior in rats influencing the DNA methylation at the 
glucocorticoid receptor (Nr3c1) and thus interfering with the stress response of the 
offspring 91. Here, the quality of maternal care of the rat dam altered the histone 
acetylation and methylation pattern of the Nr3c1 17 promoter region in the 
hippocampus of the offspring. Decreased levels of maternal care as expressed by 
reduced licking and grooming led to increased methylation at the NGFI-A binding 
site of the Nr3c1 promoter and decreased GR mRNA expression compared to 
offspring from a high-licking and grooming mother providing good maternal care. 
Offspring of low licking and grooming animals subsequently showed an altered 
behavioral but also endocrine response to stress in adulthood. Another example is 
the effect of maternal separation (a form of early life stress in rodents models) on 
DNA methylation and gene expression of the mouse Avp gene 92. Here, separation 
of the offspring from the mother animal at post-natal day 1-10 induced an increase 
in Avp mRNA expression and in turn a long-term decrease in DNA methylation at 
the Avp gene enhancer region in the offspring paraventricular nucleus potentially 
contributing to the increased secretion of corticosterone in adulthood and impaired 
behavioral response to stress after early life stress. In line with the studies on the GR 
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and Avp, Elliott et al. used a social defeat paradigm to investigate the effect of adult 
stress on DNA methylation of the corticotrophin releasing hormone gene (Crh) in 
mice and found demethylation of the Crh promoter region in stress-susceptible 
compared to resilient animals 93. Finally, Fkbp5 has also been investigated with 
respect to epigenetic modifications. Although no direct evidence for a stress-
dependent epigenetic regulation of Fkbp5 in rodent models has been observed, in-
vivo GR activation by corticosterone is sufficient to induce an intermediate 
demethylation in Fkbp5 suggesting that Fkbp5 methylation may be an indicator for 
corticosterone release and thus measure of stress exposure in mice 65,94. The 
mechanism by which GR activation can lead to a local demethylation in and around 
GREs remains elusive although GR induced demethylation has been described 
before and DNA strand break repair mechanisms might be involved in this process 
95,96. Although no direct evidence exist, active demethylation at GREs can also 
involve intermediate steps such as hydroxymethylation, a form of DNA methylation 
that has been described to be an intermediate step of DNA demethylation by other 
transcription factors 97,98.   
 
Parallel to studies in animal models, first investigations in monozygotic (i.e. 
genetically identical) twins showed that even at birth detectable gene expression 
differences exist, potentially linking the intrauterine environment to epigenetic 
factors influencing gene transcription 99. Further studies on monozygotic twins also 
showed that even while no epigenetic differences at birth were detectable, 
monozygotic twins develop divergent DNA methylation and histone acetylation 
profiles over their lifetime suggesting a differential influence of the environment 100. 
In line with these observations, more recent studies have stratified monozygotic 
twins according to the presence of psychiatric traits or disorders in one twin and 
compared the epigenetic profile between twin pairs suggesting varying epigenetic 
pattern according to disease state 101-104. Nevertheless, a stochastic drift in DNA 
methylation and other factors such as allelic expression contribute to the differences 
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observed as well. Other examples supporting the influence of the environment on 
the epigenome in humans are epidemiological studies on individuals exposed to 
severe food restriction 105-107. Here, periconceptional caloric restriction during the so-
called Dutch hunger winter during World War II was associated with DNA 
methylation differences at the IGF2 locus 106 but also on a global scale leading to 
metabolic differences in exposed vs. unexposed individuals in later life potentially 
influencing the risk for subsequent disease 105.  
 
Similar to the studies by Weaver et al on the rat Nr3c1 17 promoter methylation in 
response to maternal care 91, McGowan et al showed that childhood abuse in 
humans is associated with increased DNA methylation at the human 1F GR promoter 
site (the orthologue of the rat 17 promoter) in postmortem hippocampal tissue 108. 
The overall expression of the glucocorticoid receptor was lower in individuals with 
the history of childhood abuse compared to non-abused individuals. Suderman et al. 
expanded these focused studies and compared the DNA methylation profile of 6.5 
million nucleotides around the NR3C1 locus in human samples of individuals 
exposed to childhood abuse and controls with samples of the rat maternal care 
paradigm 109. The gene promoter methylation levels were comparable between the 
two species suggesting a similar cross-species response to early life stress and the 
overall DNA methylation changes included both hypomethylated regions as well as 
hypermethylated regions suggesting a differential and region specific response. 
Moreover, the human differential methylated regions were enriched in promoter as 
well as last exon regions containing regulatory elements linked to gene expression 
regulation. Interestingly, the most prominent differences were not observed at the 
NR3C1 locus but at the protocadherin gene locus with increased DNA methylation 
in abused human samples paralleled by an increased methylation in low maternal 
care samples in rat. 
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Besides the prominent example of glucocorticoid receptor DNA methylation with 
regard to maternal behavior as well as childhood abuse, numerous studies have 
used predominantly case-control designs to investigate DNA methylation 
differences in human cohorts. Here, neuronal tissue is largely unavailable in large 
cross-sectional studies. Therefore peripheral tissue such as whole blood, FACS 
sorted PBMCs; spit or buccal cells are leveraged to determine an overall methylation 
pattern between case and control subjects. Because of the strong influence of stress 
in early childhood, most studies investigate the effect of childhood trauma and early 
stressful life events. Other studies investigated the epigenetic signature of 
psychiatric phenotypes such as MDD or PTSD compared to age- and sex-matched 
controls. The initial studies based on hypothesis driven candidate genes have been 
recently replaced and extended by genome wide approaches using array 
technology or next generation sequencing. Examples for these studies are 
summarized in Table 1.  
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Study 
Demographic 
details 
Environmental 
exposure or 
phenotype 
Outcome 
phenotype 
Tissue 
investigated 
Gene(s) 
analyzed 
Findings 
McGowan 
et al. 
2009108 
N=36, males only, 
N=12 for 
abuse+suicide, 
N=12 for non-
abused+suicide, 
N=12 controls 
Childhood 
Experience of 
Care and 
Abuse 
Questionnaire   
Suicide 
post-mortem 
hippocampal 
brain tissue 
Promoter 
region 1F of 
NR3C1 by 
bisulfite 
mapping 
Increased Methylation of 
1F Promoter, leading to  
decreased NGFI-A 
binding and reduced 
hippocampal 
glucocorticoid receptor 
(NR3C1) expression in 
suicide victims with 
childhood abuse 
Alt et al., 
2010110 
N=12, N=6 MDD, 
N=6 controls, 
male=7, female=5 
  MDD 
Samples of 
different 
brain tissues 
Several GR 
promoter 
regions 
including 1F by 
pyrosequencing 
No differences in GR 
promoter methylation 
observed although 
expression of GR 
isoforms and NGFI-A 
transcription factor was 
altered in MDD vs. 
controls 
Uddin et al., 
2010111 
N=100, N=23 for 
PTSD+, N=77 for 
PTSD-, male=40, 
female=60 
Different 
trauma types 
from a list of 
19 diverse 
events 
PTSD 
Peripheral 
blood 
14495 genes by 
Illumina 27k 
BeadChip 
Results were stratified 
according to uniquely 
methylated/unmethylated 
gene in each group. The 
number of uniquely 
methylated genes was 
significantly higher in 
PTSD affected patients 
with an enrichment of 
immune related genes 
Smith et al., 
2011112 
N=110, N=25 for 
PTSD+childhood 
trauma, N=26 for 
controls+childhood 
trauma, N=34 for 
controls with no 
childhood trauma 
Childhood 
Trauma 
Questionaire 
(CTQ) 
PTSD 
Peripheral 
blood 
Global and site-
specific 
methylation by 
Illumina 27k 
BeadChip 
Increased global 
methylation in subjects 
with PTSD. CpG sites in 
five genes (TPR, CLEC9A, 
APC5, ANXA2, and TLR8) 
were differentially 
methylated in subjects 
with PTSD compared to 
controls. Enrichment of 
immune related genes. 
Uddin et al., 
2011113 
N=100, N=33 for 
MDD, N=67 for 
controls  
  Depression 
Peripheral 
blood 
14495 genes by 
Illumina 27k 
BeadChip 
Similar to Uddin et al., 
2010, individuals were 
stratified according to 
disease status. Individuals 
with depression showed 
less uniquely methylated 
and unmethylated genes. 
An enrichment of 
inflammatory genes was 
detected.   
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Fuchikami 
et al., 
2011114 
N=38, N=20 for 
MDD, N=18 for 
controls 
  MDD 
Peripheral 
blood 
BDNF by 
Sequenom 
EpiTYPER 
 
Patients with MDD and 
healthy controls showed 
significantly different 
methylation profile at the 
exon I of BDNF (hyper- 
and hypomethylation) 
suggesting a disease 
specific methylation 
profile 
Rusiecki et 
al., 2012115 
N=150 US soldiers, 
N=75 post 
deployment PTSD, 
N=74 no PTSD, 
males=100, 
females=50 
Afghanistan 
war, 
Deployment 
as a proxy for 
trauma 
exposure 
PTSD 
Peripheral 
blood 
LINE-1 and Alu 
by 
pyrosequencing 
LINE-1: hypermethylated 
in controls post- versus 
pre-deployment and 
hypomethylated in cases 
versus controls 
postdeployment, Alu: 
hypermethylated for 
cases versus controls 
predeployment, genomic 
location of individual 
retrotransposons not 
determined 
Sabunciyan 
et al., 
2012116 
N=65, N=39 for 
MDD, N=26 for 
controls 
  MDD 
Postmortem 
frontal 
cortex brain 
tissue 
Genome-wide 
DNA 
methylation by 
CHARM 
224 candidate regions 
with DNA methylation 
differences >10%. These 
regions are highly 
enriched for neuronal 
growth and development 
genes 
Alasaari et 
al., 2012117 
N=49, N=24 with 
high stress levels, 
N=25 with low 
stress levels 
  
Burnout/ 
Depression 
Peripheral 
blood 
SLC6A4 by 
bisulfite sanger 
sequencing  
Nurses with stress had 
significantly lower 
promoter methylation 
levels at all five CpG 
residues compared to 
nurses with low stress. No 
association of 
Burnout/Depression with 
methylation levels 
Labonte et 
al., 2012118 
N=61, N=61 for 
suicide+abuse, 
N=20 for suicide-
abuse, N=16 for 
controls, all males 
CECA.Q 
Childhood 
Experience of 
Care and 
Abuse 
Questionnaire 
Suicide 
Hippo-
campal 
samples 
Genome-wide 
DNA 
methylation by 
MeDIP-chip 
362 differentially 
methylated promoters in 
individuals with a history 
of abuse compared with 
controls. Genes involved 
in cellular/neuronal 
plasticity were 
significantly enriched 
Yang et al., 
2013119 
N=192, N=96 for 
abuse, N=96 for 
Childhood 
trauma 
  Saliva 
Genome-wide 
DNA 
Significantly different 
methylation at 2868 CpG 
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controls, 42% 
males 
methylation by 
Illumina 450k 
Array 
sites in numerous genes 
related to health 
problems between 
abused vs control 
individuals 
Melas et al., 
2013120 
N=1668, N=392 
for MDD, N=1276 
for controls, 
males=675, 
females=993 
  Depression Saliva 
MAOA and 
NR3C1 by 
Sequenom 
EpiTYPER 
MAOA methylation levels 
were decreased in 
depressed females 
compared to controls 
Kang et al., 
2013121 
N=108    MDD 
Peripheral 
blood 
SLC6A4 by 
pyrosequencing 
Higher SLC6A4 promoter 
methylation significantly 
associated with 
childhood adversities, 
family history of 
depression, higher 
perceived stress, and 
more severe 
psychopathology 
Zhao et al., 
2013122 
n=168, Caucasian, 
84 twim pairs 
discordant for 
MDD 
MDD 
Depressive 
symptoms 
Peripheral 
blood 
 SLC6A4 by 
pyrosequencing 
Variation in DNA 
methylation level of the 
serotonin transporter 
gene promoter region is 
associated with variation 
in depressive symptoms 
with increasd methylation 
in response to increased 
depression symptoms 
 
Table 1. Examples for candidate gene and genome-wide studies on DNA methylation on stress-
related psychiatric disorders and early life trauma in humans. Table taken and adapted from Klengel 
et al., Neuropharmacology, 2014123. 
 
A major limitation of these representative examples is that none of these studies 
account for the genetic heterogeneity present in human cohorts, a confounder that 
has been already shown to influence the DNA methylation pattern 124,125. In addition, 
the studies highlighted above are predominantly descriptive and allow only minimal 
insight into the molecular mechanisms of environmentally induced epigenetic 
changes with regard to the underlying pathomechanisms of psychiatric disorders.  
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The first paper in the following chapter investigates the molecular mechanism of the 
GxE of FKBP5 and childhood abuse and provides evidence for the functional SNP 
mediating the genetic effect of this GxE. This paper shows for the first time that a 
common SNP can influence the three-dimensional structure of the FKBP5 locus 
leading to an enhanced transcriptional response to stress. In addition, this paper 
provides evidence for genotype-dependent epigenetic modifications in response to 
environmental factors.  
 
The second paper investigates the gene expression signature as well as the 
corresponding DNA methylation profile on a genome wide level in individuals 
suffering from PTSD exposed to adult and childhood trauma versus individuals 
exposed to adult trauma only. This paper provides evidence for distinct epigenetic 
and transcriptional signatures in response to childhood abuse compared to adult 
trauma suggesting divergent molecular mechanisms involved in the pathogenesis of 
PTSD depending on the type and timing of the disease-causing traumatic event.  
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Paper I 
   
Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, Pace 
TWW, Mercer KB, Mayberg HS, Bradley B, Nemeroff CB, Holsboer F, Heim CM, 
Ressler KJ, Rein T, Binder EB. Allele–specific DNA FKBP5 demethylation: a 
molecular mediator of gene–childhood trauma interactions. Nature Neuroscience. 
16(1), 33-41, 2013 doi:10.1038/nn.3275.  
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Epidemiological, family and molecular genetic studies have shown 
that genetic predisposition as well as stressful or traumatic life events, 
especially in childhood, are important risk factors for psychiatric dis-
orders, including major depression and post-traumatic stress disorder 
(PTSD) and that these factors most likely have interactive, rather than 
additive, effects1. Although specific gene × environment interactions 
have been described2–5, the molecular basis of gene × environment 
interaction in mood and anxiety disorders remains obscure. FKBP5 
is an important functional regulator of the glucocorticoid receptor 
complex6. The glucocorticoid receptor is a pivotal nuclear receptor 
of the stress hormone system mediating the negative feedback of 
this axis to terminate the stress response after the end of a threat7. 
Dysregulation in this system has been described in stress-related 
psychiatric disorders and as a long-term consequence of exposure to 
early life trauma8,9. FKBP5 alters glucocorticoid receptor function by 
decreasing ligand binding and impeding translocation of the recep-
tor complex to the nucleus10,11. Furthermore, FKBP5 is part of an 
intracellular ultra-short negative feedback loop that regulates gluco-
corticoid receptor activity. Glucocorticoid receptor activation induces 
FKBP5 transcription via activation at predominantly intronic ster-
oid hormone response elements12, leading to increased transcription 
of FKBP5, entailing restrained glucocorticoid receptor activity. 
We and others have shown that polymorphisms in FKBP5 (haplotypes 
including rs1360780, rs9296158, rs3800373 and rs9470080) interact 
with early trauma or childhood abuse to predict adult PTSD, suicide 
attempts and major depression3,13–17. Here we identified a molecular 
mechanism for this gene × environment interaction by long-term 
epigenetic modifications.
RESULTS
rs1360780 moderates the risk for PTSD after early trauma
Previously, we found that the same FKBP5 polymorphisms that inter-
act with early trauma are also associated with altered induction of 
FKBP5 mRNA by glucocorticoid receptor stimulation in peripheral 
blood18. We hypothesized that the associated functional variant lies 
in or close to glucocorticoid response elements (GREs) in the FKBP5 
locus. Given that the originally genotyped variants are in high link-
age disequilibrium over the entire locus, we used genotype data from 
Illumina OmniExpress Single Nucleotide Polymorphism (SNP) arrays 
spanning the whole FKBP5 locus in 192 individuals of the Grady 
trauma project and imputed all currently known variants using the 
1,000 Genomes project data (http://www.1000genomes.org/)19. This 
resulted in 799 polymorphisms imputed with a quality greater than 
0.6 and an average quality score of 0.93. Linkage disequilibrium 
with rs1360780, rs9296158, rs9470080 and rs3800373 was evaluated 
using the tagger software implemented in Haploview version 4.2. 
Of the imputed polymorphisms, 48 had an r2 greater than 0.4 with 
at least one of the four polymorphisms mentioned above to interact 
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Allele-specific FKBP5 DNA demethylation  
mediates gene–childhood trauma interactions
Torsten Klengel1, Divya Mehta1, Christoph Anacker2, Monika Rex-Haffner1, Jens C Pruessner3,  
Carmine M Pariante2, Thaddeus W W Pace4, Kristina B Mercer5, Helen S Mayberg4, Bekh Bradley4,6,  
Charles B Nemeroff7, Florian Holsboer1, Christine M Heim4,8, Kerry J Ressler4,5,9, Theo Rein1 & Elisabeth B Binder1,4
Although the fact that genetic predisposition and environmental exposures interact to shape development and function of the 
human brain and, ultimately, the risk of psychiatric disorders has drawn wide interest, the corresponding molecular mechanisms 
have not yet been elucidated. We found that a functional polymorphism altering chromatin interaction between the transcription 
start site and long-range enhancers in the FK506 binding protein 5 (FKBP5) gene, an important regulator of the stress 
hormone system, increased the risk of developing stress-related psychiatric disorders in adulthood by allele-specific, childhood 
trauma–dependent DNA demethylation in functional glucocorticoid response elements of FKBP5. This demethylation was linked 
to increased stress-dependent gene transcription followed by a long-term dysregulation of the stress hormone system and a 
global effect on the function of immune cells and brain areas associated with stress regulation. This identification of molecular 
mechanisms of genotype-directed long-term environmental reactivity will be useful for designing more effective treatment 
strategies for stress-related disorders.
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with early trauma and these variants spanned 192 kb of the locus 
(Supplementary Table 1). Of all genotyped and imputed variants 
tagging this association, rs1360780, the variant originally identified 
as being associated with differential induction of FKBP5 by gluco-
corticoid receptor activation18, was the SNP in the tagging bin that was 
located closest to a functional GRE (see detailed description below).
In an expanded African-American cohort (N = 1,963) from the 
Grady trauma project (which includes 1,194 more individuals than 
were present in our original report3), we first confirmed and extended 
our previously reported interaction of FKBP5 rs1360780 and early 
trauma on adult PTSD symptoms. We not only observed a significant 
interaction of child abuse, determined by the Childhood Trauma 
Questionnaire (CTQ) and FKBP5 rs1360780, on current adult PTSD 
symptoms, as measured by the modified PTSD symptom scale (mPSS 
total score, F1963,2 = 4.40, P = 0.012), but also on lifetime PTSD, as 
assessed by the criterion standard diagnostic instrument, the clinician-
administered PTSD scale (CAPS, N = 519). In a logistic regression ana-
lysis, both early trauma (P < 0.001) and the interaction of early trauma 
and the FKBP5 rs1360780 risk allele carrier status (P = 0.034) were 
significant predictors for lifetime PTSD without main genetic effect 
of FKBP5. The risk of suffering from lifetime PTSD was significantly 
increased by exposure to early trauma in FKBP5 risk allele carriers 
(χ2 = 28.6, degrees of freedom = 2, P < 0.001), but not in carriers of 
the protective genotype (χ2 = 2.02, degrees of freedom = 2, P = 0.36) 
(Fig. 1). These data lend further support to the robustness of the 
moderation of child abuse–related risk for adult PTSD by rs1360780.
rs1360780 affects FKBP5 chromatin shape and transcription
The glucocorticoid receptor transcriptionally regulates FKBP5 
mainly by distal intronic GREs20. rs1360780 is located in a functional 
enhancer region and 488 bp from a GRE in intron 2. To test whether 
this SNP itself has the potential to alter FKBP5 transcription, we 
cloned reporter gene constructs encompassing the consensus GRE 
site together with either the rs1360780 A/T risk allele or the C/G 
protective allele (Fig. 2a). The construct with the risk allele exhibited 
stronger activity than the construct with the protective allele, both 
in the absence of glucocorticoid receptor (1.4-fold, P < 0.001) and in 
the presence of activated glucocorticoid receptor (1.7-fold, P = 0.036) 
(Fig. 2b,c). These data are consistent with previously reported in vivo 
data showing a stronger correlation of FKBP5 mRNA and plasma 
cortisol in peripheral blood cells from risk genotype carriers as com-
pared with carriers of the protective allele18. In fact, the sequence 
containing the A/T risk allele of rs1360780 is predicted to form a 
putative TATA box, possibly enhancing gene transcription as com-
pared to the C/G allele. The A allele indeed exhibited a stronger TATA 
box binding protein (TBP) binding than the G allele (P = 0.009; Fig. 
2d). Data from chromatin immunoprecipitation experiments sug-
gest that this distal GRE comes into contact with RNA polymerase 
and, likely, the transcription start site (TSS), supporting a functional 
consequence of altered TBP binding in intron 2 on FKBP5 mRNA 
Figure 2 Genotype- and glucocorticoid 
receptor–dependent enhancer activities of intron 
2 sequences of FKBP5. (a) Representation of the 
reporter construct. The luciferase gene is driven 
by a basal human elongation factor-1 alpha  
(EF-1α, EEF1A1) promoter with a 802-bp fragment 
of FKBP5 intron 2 containing the putative GRE 
and rs1360780 cloned in front of the promoter. 
The rs1360780 risk allele A/T might form a 
TATA box–like sequence, which would enhance 
transcriptional activity. (b) Allele specificity of the  
reporter gene activity in glucocorticoid receptor–
free HEK 293 cells. The reporter activity was 
reduced for the protective allele versus the risk 
allele (***P < 0.001, Student’s t test, unpaired,  
two sided). (c) Stimulation with 50 nM dexametha-
sone significantly enhanced intron 2–driven 
luciferase activity in glucocorticoid receptor–
expressing HeLa cells in a genotype-dependent 
manner. Reduced activity was observed for the 
protective allele versus the risk allele (*P = 0.036, 
Student’s t test, unpaired, two sided). Baseline luciferase activity in HeLa cells without dexamethasone stimulation did not reveal significant differences (data 
not shown). In the box plots, the box extends indicate lower quartile and upper quartile, and the whiskers denote sample minimum and maximum. The line in 
the box represents the median and dots represent outliers. (d) Relative binding of recombinant TBP to a double-stranded 60-mer oligonucleotide containing 
either the A or G allele of rs1360780. The A allele exhibited a stronger binding to TBP than the G allele. (**P = 0.009, Student’s t test, unpaired, two sided). 
The assay was run in triplicates, background activity was subtracted from the measurement reading. Data are expressed as mean ± s.e.m.
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transcription20. Taking advantage of the chromatin conformation cap-
ture technique, we found an rs1360780 genotype–independent inter-
action of intron 7 with the TSS via three-dimensional loop formation 
(Fig. 3 and Supplementary Fig. 1a–d) and a 
genotype-dependent interaction of intron 2 
and the TSS in a homozygote risk (AA) allele 
carrier, but not a carrier of the protective 
(GG) genotype. These results support the 
theory that the functional effects reported 
for the FKBP5 haplotype on FKBP5 mRNA 
and protein levels could be mediated by the 
different chromatin conformation and, thus, 
transcriptional effects of the two opposite 
alleles of rs1360780 (ref. 18).
Consistent with the ultra-short negative 
feedback between FKBP5 and glucocorticoid 
receptor activation, this genotype-mediated 
increased FKBP5 transcription has been shown 
to be associated with glucocorticoid receptor 
resistance in healthy controls3,15 and with a 
decreased efficiency of negative feedback of 
the stress hormone axis accompanied by pro-
longed cortisol release21. We sought to unravel 
the molecular mechanism by which a genetic 
predisposition to react more strongly to a stres-
sor in the short term interacts with exposure to 
childhood trauma to increase the risk of devel-
oping psychiatric disorders in the long term.
DNA demethylation in FKBP5 in 
traumatized individuals
Epigenetic changes, especially changes in DNA 
methylation, have been reported as long-lasting 
consequences of early trauma22–24, and gluco-
corticoid receptor activation has been shown 
to induce local changes in DNA methylation at 
GREs, including in the murine Fkbp5 locus25,26. 
We hypothesized that excessive cortisol release 
following early life stress exposure in FKBP5 risk allele carriers would lead 
to epigenetic changes in the GREs of FKBP5, resulting in lasting disrup-
tions of the ultra-short feedback loop that balances FKBP5 and glucocorti-
coid receptor activity, entailing dysregulation of the stress hormone system, 
and ultimately increasing the risk for certain psychiatric disorders.
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Figure 3 Long-distance interaction of GREs in FKBP5. Chromatin 
conformation capture confirmed a genotype-dependent interaction of 
the FKBP5 TSS (TSS) with intron 2 and intron 7 in lymphoblastoid cell 
lines. (a) Top, FKBP5 genomic locus with the TSS indicated by an arrow 
and intron 2 and intron 7 indicated by black boxes. The upright thin 
lines represent EcoRI cutting sites of genomic DNA. Bottom, chromatin 
conformation capture interaction data. Amplicon primers are indicated by 
small arrows, and the fragments containing the TSS, intron 2 and intron 7  
are emphasized by gray boxes. Data from quantitative PCR are plotted 
as relative crosslinking frequency on the y axis. A specific interaction 
was detected as the local peak in interaction frequencies. Thus, intron 7 
showed a stronger interaction with the TSS than with fragments upstream 
and downstream of the intron 7 fragment in both cell lines. Moreover, we 
observed a strong local peak for the interaction of the TSS with intron 2, 
but only in the cell line carrying the risk (AA) genotype. This confirmed the 
physical interaction of the TSS with intron 7 and intron 2 in a genotype-
dependent manner. (b,c) Three-dimensional interaction of intronic GREs 
in intron 2 and 7 of FKBP5 with the TSS. FKBP5 mRNA transcription is 
induced by cortisol via a three-dimensional interaction and loop formation 
of predominantly distal enhancer regions (blue) harboring GREs with the 
core promoter site (PolII = RNA polymerase II). The interaction of intron 2 
with the TSS in risk allele carriers leads to an increased FKBP5 induction in 
response to glucocorticoid receptor activation (represented by a red arrow).
Table 1 Sample description of Grady trauma project cohort and Conte Center cohort
Subjects with ≥2 childhood 
traumas (sexual and  
physical) according to TEI
Controls with no childhood 
trauma (sexual and  
physical) according to TEI
P value, χ2 or 
ANOVA
Grady trauma project cohort N = 30 N = 46
Age (mean ± s.d.) 41.46 ± 11.67 years 40.97 ± 11.86 years 0.860
Age minimum 19 years 18 years
Age maximum 59 years 61 years
Gender (female/male) 22/8 36/10 0.783
Race (N)
 African American 27 45 0.150
 Caucasian 2 0
 Mixed 1 0
 Other 0 1
mPSS total (mean ± s.d.) 26.72 ± 13.56 3.35 ± 3.53 <0.001
BDI total score 21.27 ± 12.50 4.80 ± 4.63 <0.001
CAPS score current 75.21 ± 58.74 16.35 ± 22.72 <0.001
CTQ total score 76.97 ± 20.14 29.76 ± 4.94 <0.001
CTQ sexual abuse score 17.27 ± 6.18 5.11 ± 0.38 <0.001
CTQ emotional abuse score 17.07 ± 5.06 6.17 ± 2.25 <0.001
CTQ physical abuse score 15.83 ± 5.60 6.11 ± 1.22 <0.001
Number of adult trauma (TEI) 4.10 ± 2.15 1.12 ± 1.29 <0.001
Conte Center cohort N = 56
Age mean (mean ± s.d.) 28.45 ± 6.98
Age minimum 18
Age maximum 45
Gender (female/male) 56/0
Race (N)
 African American 31
 Caucasian 17
 Mixed 2
 Other 6
BDI total score (mean ± s.d.) 9.13 ± 11.14
CTQ total score 51.98 ± 22.90
CTQ sexual abuse score 9.00 ± 5.86
CTQ emotional abuse score 12.34 ± 7.01
CTQ physical abuse score 10.23 ± 5.26
BDI, Beck Depression Inventory; TEI, Traumatic Events Inventory.
np
g
© 
20
13
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
36  VOLUME 16 | NUMBER 1 | JANUARY 2013 nature neurOSCIenCe
a r t I C l e S
To investigate the possibility that FKBP5 × 
early trauma interactions are mediated by 
epigenetic modifications, we performed DNA 
methylation analysis by pyrosequencing of 
bisulfite-treated genomic DNA extracted 
from peripheral blood cells from individuals 
selected from the Grady trauma project. 
DNA from individuals having experienced 
both sexual and physical child abuse were 
compared with DNA from individuals 
without any childhood trauma (N = 76; 
high trauma cohort, N = 30; control cohort, 
N = 46; Table 1). We screened the CpG 
island in the vicinity of the TSS, as well as 
the regions around functional GREs20 in the 
putative promoter region and introns 2, 5 and 
7 for the extent of CpG methylation (Fig. 4a 
and Supplementary Table 2). We observed 
significant DNA methylation higher than 
5% in regions close to the GREs in the pro-
moter region (30–100%), intron 2 (30–93%) 
and intron 7 (29–100%), but not in the CpG 
island or the two GREs in intron 5 (<5%). 
In intron 7, but not in the two other regions, 
two methylated CpGs were located in consen-
sus GRE sequences.
We next tested the effects of FKBP5 geno-
type (rs1360780 risk allele carrier model) 
and exposure to childhood abuse (CTQ 
categorical scale), as well as their interaction, 
on the extent of DNA methylation in these 
three regions, summarizing the percentage 
methylation of these 16 CpGs into seven bins 
of one to three CpGs to a mean methylation 
score according to their spatial proximity 
to the consensus GRE sites (Fig. 4b and 
Supplementary Fig. 2). The analyses were corrected for age and gen-
der as covariates and multiple testing. In one bin of intron 7 (bin 2), 
but not the other bins, significant early trauma (F73,1 = 8.2, P = 0.006), 
genotype (F73,1 = 34.33, P < 0.001) and interaction effects between 
genotype and early trauma (F73,1 = 31.01, Pcorr < 0.001) on meth-
ylation were observed. This bin contains three CpGs, with one CpG 
located in the consensus GRE in intron 7 (Supplementary Fig. 2). An 
average decrease of 12.3% in DNA methylation in these three CpGs 
was detected in child abuse–exposed risk allele carriers compared to 
the other three groups (Supplementary Fig. 3). When correlating 
levels of child abuse measured using the log-transformed total CTQ 
score and the subscores for physical, emotional and sexual abuse on 
this scale, with the mean methylation of this CpG bin in intron 7, we 
found significant differences in the correlation coefficients between 
the risk allele carriers (N = 55) and the protective genotype carriers 
(N = 19) (R = −0.646, P < 0.001 for risk allele and R = 0.414, P = 0.078 
for protective genotype carriers and total CTQ with a Fisher z score 
of –4.23 and P = 7.0 × 10−5; Fig. 5 and Supplementary Table 3). 
Heterozygous individuals carrying one risk allele did not differ from 
homozygous risk allele carriers (Supplementary Fig. 4). This empha-
sizes the effects of early trauma severity on FKBP5 demethylation in 
risk allele carriers, but not in protective genotype carriers.
To test whether the observed effects of child abuse may have been 
confounded by the increased exposure to more recent types of trauma 
in the abused group (Table 1), we explored the correlation of intron 7 
bin 2 DNA methylation and the number of exposures to adult trauma 
separately in risk alleles carriers with or without child abuse. We did 
not observe a correlation of exposure to adult trauma with intron 
7 bin 2 DNA methylation in either the childhood abuse risk allele 
group (R = 0.020, P = 0.933, N = 20) or the control risk allele group 
(R = 0.018, P = 0.917, N = 35). This suggests that the observed effect 
of early trauma on DNA methylation is independent of subsequent 
exposure to trauma (Supplementary Fig. 5).
We next investigated the relationship of severity of early trauma and 
FKBP5 DNA methylation in a second female-only cohort recruited 
as part of a separate study investigating the effects of early trauma 
on biological markers4,27 (Table 1). In this cohort, we correlated the 
log-transformed total CTQ score as well as the subscores for physical, 
emotional and sexual abuse with the mean DNA methylation of the 
three CpGs in the second bin of intron 7. In FKBP5 risk genotype carri-
ers (N = 33), we observed a negative correlation between the methyla-
tion score and the total CTQ score (R = −0.273, P = 0.124), the physical 
abuse subscore (R = −0.397, P = 0.022) and the emotional abuse sub-
score (R = −0.397, P = 0.022), but not the subscore for sexual abuse 
(R = 0.118, P = 0.514) (Fig. 5). In carriers of the protective genotype 
(N = 23), these correlations were either absent or positive 
(Supplementary Table 3). The difference in correlations was 
 significant for the physical abuse subscore (Fischer z score = −2.33, 
P = 0.019). These data from an independent sample support the notion 
of allele-specific demethylation of CpGs close to and in functional 
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GREs in intron 7 of the FKBP5 gene with early trauma exposure. The 
difference in effect size and relative contributions of different trauma 
types is likely a result of the fact that this second cohort was exposed 
to less overall trauma, including childhood abuse, than the cohort 
from the Grady trauma project (Table 1). In addition, the replication 
cohort was ethnically diverse, but the effects of childhood abuse on 
DNA methylation were consistent across the two main ethnic groups, 
European and African Americans.
To rule out the possibility that trauma- or psychiatric disease–
related differences in immune cell fractions confound the reported 
results28, we reran the analysis in 41 women of the replication cohort 
(21 risk allele carriers, 20 protective genotype carriers) in whom we 
also had data on the relative amount of the main immune cell subtypes 
(CD14-positive monocytes and neutrophils, CD4- and CD8-positive 
lymphocytes, and CD16- and CD56-positive NK cells). Using these as 
covariates, we found that the differences in correlations between CTQ 
scores and intron 7 methylation in the two genotype groups remained 
substantial. For physical abuse, the corrected correlations were 
R = −0.476 in risk allele carriers and R = 0.40 in carriers of the protec-
tive genotype, with a significant z score of 2.78 (P = 0.005). In addi-
tion, we did not observe any correlations between the relative amount 
of immune cell subtypes and intron 7 DNA methylation, suggesting 
that possible trauma-related differences in these cell types are not 
likely to confound our results. However, we cannot exclude the effect 
of immune cell subtypes that were not specifically tested.
Demethylation of FKBP5 in neuronal cells
Our data therefore point to an allele-specific, early trauma exposure–
dependent demethylation of CpGs close to and in GREs in intron 7 
of FKBP5 (Supplementary Fig. 1a–d). To determine whether this 
demethylation could be related to excessive glucocorticoid receptor 
activation and might also be seen in tissues other than peripheral 
blood, including neuronal tissue, we used a multipotent human hippo-
campal progenitor cell line in which exposure to dexamethasone has 
been shown to be accompanied by a reduction in cell proliferation 
and neuronal differentiation29. Cells were exposed to dexamethasone 
during both the proliferation and differentiation phases, similar to 
previous studies29. The percentage of DNA methylation across CpGs 
in introns 2 and 7 in these neuronal progenitor cells was comparable 
to that in peripheral blood cells. Exposure to dexamethasone led to a 
highly significant (P < 0.001) DNA demethylation in CpGs in intron 7, 
but not intron 2 (Fig. 6a). In fact, the CpG bin in intron 7 that was 
affected by early trauma in FKBP5 risk allele carriers showed the 
strongest DNA demethylation following glucocorticoid receptor 
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Figure 5 Differential FKBP5 intron 7 DNA methylation depends on genotype and trauma exposure. Correlation between intron 7 bin 2, mean 
methylation and log-transformed CTQ scores by FKBP5 rs1360780 genotype in the Grady and Conte cohort are shown. (a) Grady cohort. Risk allele 
carriers exhibited a strong negative correlation (R = −0.646, P < 0.001) between methylation and CTQ total load compared with carriers of the 
protective genotype (R = 0.414, P = 0.078) (Fisher z score = −4.23, P < 0.001). (b) Conte cohort. Correlation between methylation and total CTQ  
in risk allele carriers (R = −0.273, P = 0.124), and in carriers of the protective genotype (R = 0.153, P = 0.485) (Fisher z score = −1.5, P = 0.133).  
(c) Grady cohort. Negative correlation was found between methylation and the CTQ physical abuse subscore in risk allele carriers (R = −0.586,  
P < 0.001), but not in carriers of the protective genotype (R = 0.360, P = 0.130) (Fisher z score = −4.49, P < 0.001). (d) Conte cohort. Negative 
correlation was observed between methylation and the CTQ physical abuse subscore in risk allele carriers (R = −0.397, P = 0.022), but not in carriers 
of the protective genotype (R = 0.246, P = 0.258) (Fisher z score = −2.33, P = 0.019). (e) Grady cohort. Negative correlation was found between 
methylation and the CTQ emotional abuse subscore in risk allele carriers (R = −0.685, P < 0.001), but not in carriers of the protective genotype  
(R = 0.321, P = 0.181) (Fisher z score = −4.1, P < 0.001). (f) Conte cohort. Negative correlation was found between methylation and the CTQ 
emotional abuse subscore in risk allele carriers (R = −0.397, P = 0.022), but not in carriers of the protective genotype (R = 0.022, P = 0.922) (Fisher 
z score = −1.53, P = 0.126). (g) Grady cohort. Negative correlation was found between methylation and the CTQ sexual abuse subscore in risk allele 
carriers (R = −0.656, P < 0.001), but not in carriers of the protective genotype (R = 0.599, P = 0.007) (Fisher z score = −5.17, P < 0.001). (h) Conte 
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np
g
© 
20
13
 N
at
ur
e A
m
er
ic
a,
 In
c.
 A
ll 
rig
ht
s 
re
se
rv
ed
.
38  VOLUME 16 | NUMBER 1 | JANUARY 2013 nature neurOSCIenCe
a r t I C l e S
stimulation in hippocampal progenitor cells (average of 17.1% 
demethylation in these three CpGs, P < 0.001 for differentiation 
phase, which includes proliferation). The observed demethylation 
in intron 7 remained unchanged after 20 days in culture in steroid- 
devoid medium, supporting a stable epigenetic memory of 
glucocorticoid-induced demethylation (Fig. 6b). Moreover, gluco-
corticoid receptor activation by dexamethasone treatment after 
proliferation and differentiation did not result in demethylation in 
intron 7 bin 2, suggesting a sensitive period of time for glucocorticoids- 
mediated epigenetic changes (Fig. 6c).
The existence of a sensitive time period for these epigenetic effects 
was also apparent from data from human blood cells, as only exposure 
to child abuse, but not later trauma, predicted FKBP5 demethylation 
(see above), and there was a lack of correlation of serum cortisol levels 
and DNA methylation in blood samples from both human cohorts 
taken at the same time point (Grady trauma project, R = 0.083, P = 0.489, 
N = 72; Conte replication cohort, R = 0.069, P = 0.603, N = 59; 
Supplementary Fig. 6). These data further substantiate the conclu-
sion that these specific CpGs in intron 7 are sensitive to stable, gluco-
corticoid receptor–mediated demethylation during a vulnerable time 
period and that our findings of early trauma–and genotype-dependent 
demethylation also pertain to tissues beyond peripheral blood.
Functional effects of intron 7 demethylation
We then investigated whether the observed changes in DNA methy-
lation in intron 7 alter the glucocorticoid responsiveness of FKBP5 
in vitro and in vivo. We inserted 515 bp of intron 7, encompassing the 
three functional GREs, into a CpG-free reporter plasmid30 (Fig. 7a) 
and assessed its activity in HeLa cells as a function of insert 
 methylation. No effect of methylation was observed in the absence 
of glucocorticoid receptor activation, which is consistent with the 
absence of correlation between intron 7 methylation and base-
line FKBP5 expression in peripheral blood cells (data not shown). 
However, methylation significantly attenuated the response to 50 nM 
dexamethasone (relative induction = 19-fold in unmethylated versus 
13-fold in methylated construct, P = 0.035; Fig. 7b). These data indi-
cate that methylation of CpGs surrounding the functional GREs in 
intron 7 decreases the induction of FKBP5 by glucocorticoid receptor 
activation without affecting baseline activity.
To test whether intron 7 DNA methylation alters the ultra-short 
feedback loop between glucocorticoid receptor and FKBP5, and 
thereby alters glucocorticoid receptor sensitivity, we correlated the 
mean methylation score of intron 7 bin 2 with glucocorticoid recep-
tor sensitivity measured ex vivo in peripheral blood monocytes in 32 
individuals from the replication cohort. We observed a strong nega-
tive correlation between the half-maximal inhibitory concentration 
(IC50) for dexamethasone-mediated inhibition of lipopolysaccharide-
induced interleukin 6 production in these cells (N = 32, R = −0.531, 
P = 0.002), which is a measure of glucocorticoid receptor sensitivity. 
This suggests that, as expected, less methylation of intron 7 CpGs is 
associated with higher induction of FKBP5 by glucocorticoid receptor 
activation, especially in risk allele carriers, representing an enhance-
ment of the ultra-short feedback loop leading to increased glucocor-
ticoid receptor resistance (Fig. 7c).
Global effect on gene transcription and brain structure
FKBP5 risk allele carrier status and early trauma exposure lead to 
demethylation of intron 7 CpGs in FKBP5, which further amplifies 
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Figure 6 Effects of glucocorticoid receptor agonist treatment on FKBP5 DNA methylation in hippocampal progenitor cells. (a) Dexamethasone  
treatment induced demethylation in the human hippocampal progenitor cell line HPC03A/07 in the proliferation and differentiation phase in  
intron 7 (***P < 0.001), but not intron 2. Data are expressed as mean ± s.e.m. (b) Dexamethasone treatment of human hippocampal progenitor cells in  
proliferation and differentiation phase resulted in significant demethylation of CpGs in FKBP5 intron 7, bins 2 and 3 (***P < 0.001, **P = 0.01,  
n.s. P > 0.05, Student’s t test, unpaired, two-sided). Dexamethasone treatment in the proliferation phase only resulted in similar demethylation of CpGs 
in FKBP5 intron 7 in comparison with the differentiation phase (data not shown). A subsequent washout of dexamethasone and an additional 20-d 
incubation revealed similar results, supporting a long-lasting demethylation in bins 2 and 3. Data are expressed as mean ± s.e.m. (c) Treatment  
in proliferation and differentiation phase resulted in an immediate demethylation of intron 7 bin 2 (***P < 0.001, Student’s t test, unpaired,  
two-sided). Treatment in the proliferation and differentiation phase and subsequent washout phase in steriod-devoid medium for 20 d revealed  
a stable demethylation by glucocorticoid receptor activation. In contrast, dexamethasone treatment after proliferation and differentiation did not 
induce a long-lasting demethylation in intron 7 bin 2 (n.s. P = 0.063, Student’s t test, unpaired, two-sided), suggesting a sensitive period of time for 
glucocorticoids-mediated epigenetic changes. Data are expressed as mean ± s.e.m.
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genotype-dependent differences in the FKBP5 and glucocorticoid 
receptor ultra-short feedback loop and, thus, glucocorticoid receptor 
sensitivity. FKBP5 genotype–dependent differences in the global reg-
ulation of glucocorticoid receptor–sensitive genes should therefore 
be amplified in trauma-exposed risk allele carriers compared with 
protective genotype carriers. To test this hypothesis, we examined 
the effects of FKBP5 rs1360780 genotype × environment interaction 
on peripheral blood mRNA expression of glucocorticoid receptor– 
responsive genes, as measured by gene expression arrays, in 129 
individuals (child abuse + risk allele, N = 40; child abuse + protective 
genotype, N = 15; no child abuse + risk allele, N = 60; no child abuse + 
protective genotype, N = 14)15. In all 129 individuals, 1,627 tran-
scripts showed a significant correlation (P < 0.05) with plasma cortisol 
concentrations, suggesting that they are responsive to glucocorticoid 
receptor activation. We found significant differences in the cor-
relation of 76 of these transcripts with cortisol plasma levels 
when stratifying by FKBP5 genotype in individuals with child 
abuse (Fisher z score ≥ 1.96; Supplementary Table 4). For these 
76 transcripts, the mean absolute correlation coefficient with plasma 
cortisol was R = 0.23 in the risk allele carriers with child abuse (that is, 
those exhibiting a demethylation of FKBP5 intron 7) as compared 
with R = 0.74 in the carriers of the protective genotype with child 
abuse (in which intron 7 methylation remained largely stable). This 
indicates a relative glucocorticoid receptor resistance in the trauma-
exposed FKBP5 risk allele versus protective genotype carriers. These 
76 transcripts did not show a genotype-dependent difference in 
FKBP5 intron 7 element
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Figure 7 Functional effects of FKBP5 intron 7 
methylation. (a) Representation of the reporter 
construct. A 514-bp fragment of FKBP5 intron 
7 containing three putative GREs was cloned in 
front of the EF-1α promoter and the luciferase 
gene, acting as transcriptional regulator. Only 
the FKBP5 insert can be methylated in vitro 
by MSssI, as the vector is CpG free. Circled 
M denotes putative methylation sites. Two of 
them are located in consensus GRE sequences. 
(b) Stimulation by 50 nM dexamethasone was 
attenuated by DNA methylation (*P = 0.035, 
n.s. P = 0.146, Student’s t test, unpaired, 
two-sided). Baseline luciferase activity without 
dexamethasone stimulation did not reveal 
significant differences (P > 0.05; data not 
shown). In the box plots, the box extends 
indicate lower quartile and upper quartile, 
and the whiskers denote sample minimum 
and maximum. The line in the box represents 
the median and dots represent outliers. 
(c) Methylation in intron 7 was correlated 
with dexamethasone-mediated inhibition of 
lipopolysaccharide-induced interleukin 6 
production (DEX IC50) in peripheral blood 
monocytes ex vivo (R = −0.531, P = 0.002). 
This correlation was stronger in rs1360780 risk 
allele carriers (N = 19, R = −0.691, P = 0.001) 
than carriers of the protective genotype (N = 13, 
R = −0.119, P = 0.698). This suggests that 
lower DNA methylation in intron 7 leads to 
stronger FKBP5 induction and to glucocorticoid 
receptor resistance. (d) Exposure to early 
trauma enhanced FKBP5 genotype–dependent 
differences in glucocorticoid receptor–dependent 
gene expression in peripheral blood. Top,  
R scores of the correlation of peripheral  
blood gene expression and cortisol for the  
76 transcripts with significant genotype-
dependent correlation differences in  
individuals with high levels of early trauma 
(cases, N = 55) and stratified by FKBP5 
genotype (risk allele: N = 40, CTQ total  
score = 67.88 ± 14.71; protective genotype: 
N = 15, CTQ total = 72.44 ± 17.68). For all 
transcripts, the correlation with cortisol, and 
therefore the presumable responsiveness to the 
glucocorticoid receptor, was higher in FKBP5 
protective genotype carriers (black squares) 
with a mean R of 0.74 than in carriers of the 
risk allele (open squares), with a mean R of 0.23. Bottom, correlation between gene expression levels and cortisol of the same transcripts, but in 
individuals that were not exposed to early trauma (controls, N = 74; risk allele: N = 60, CTQ total = 28.42 ± 2.96; protective genotype: N = 14,  
CTQ total = 28.79 ± 3.21). In this group, no genotype-dependent differences of the correlation were observed, with mean R scores of 0.31 and  
0.35 for risk and protective genotypes, respectively. x axis represents individual transcripts 1 to 76.
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correlation coefficients in individuals that were not exposed to child 
abuse (Fig. 7d), suggesting that exposure to early trauma enhances 
the FKBP5 genotype–dependent effect of glucocorticoid receptor 
sensitivity, most likely by epigenetic mechanisms. The genes most 
strongly affected by FKBP5 genotype for their correlation with 
plasma cortisol levels in trauma-exposed individuals showed a signi-
ficant over-representation (WikiPathways, P < 0.01) of transcripts 
in the T cell receptor signaling pathway (Padjusted = 5.15 × 10−7), 
the TGF-β signaling pathway (Padjusted = 0.0007), the Wnt signaling 
pathway and pluripotency (Padjusted = 0.0044), and the inflamma-
tory response pathway (Padjusted = 0.0099)31. These findings suggest 
that the combination of FKBP5 risk allele carrier status and early 
trauma exposure alters the stress hormone–dependent regulation of 
several genes in peripheral blood cells, and might thereby enhance 
the reported association of early trauma with immune and inflam-
matory dysregulation, further promoting system-wide symptoms of 
stress-related disorders32,33.
Structural imaging data from a subset of the replication cohort 
revealed that peripheral blood FKBP5 methylation significantly cor-
related with the volume of the right hippocampal head (N = 34, R = 
−0.484, Pcorr = 0.014; Supplementary Fig. 7). Despite the smaller N val-
ues for the structural imaging data in the less-traumatized replication 
cohort, these preliminary data suggest that FKBP5 demethylation is not 
only associated with an altered sensitivity of peripheral glucocorticoid 
receptors and more global changes in immune cell gene expression, 
but also with morphological changes in the brain indicative of a higher 
stress hormone system reactivity, thereby bridging the gap between 
abuse-related peripheral methylation changes and effects in the CNS.
DISCUSSION
Here we provide evidence for an epigenetic mechanism that mediates the 
combined effects of environmental exposure in early life and a genetic 
polymorphism on the risk of developing stress-related psychiatric dis-
orders. According to this mechanism, genetic variations shaped by evo-
lution can determine the environmental adaption during the lifetime 
of an individual via epigenetic processes. Our data suggest the follow-
ing scenario for an FKBP5 × child abuse interaction (Supplementary 
Fig. 1a–d): genetic differences lead to divergent chromatin conforma-
tions and interactions of long-range enhancers with the TSS, resulting 
in a differential transcriptional activation of FKBP5 by glucocorticoid 
receptor activation in response to childhood abuse. These changes in 
chromatin structure include regions around distal GREs and, together 
with increased cortisol levels and thus glucocorticoid receptor binding, 
lead to changes in DNA methylation in intron 7, further increasing the 
differential responsiveness of FKBP5 to glucocorticoid receptor acti-
vation. When installed during developmentally critical periods, these 
epigenetic changes remain stable over time. This model describes how 
epigenetic mechanisms stabilize and, in an environment-dependent 
manner, further amplify differential activities that were originally 
bestowed on the enhancer complex by genetic differences.
On a systems level, these molecular changes further tighten the 
ultra-short feedback loop between FKBP5 and the glucocorticoid 
receptor leading to glucocorticoid receptor resistance. Enhanced 
FKBP5 responsiveness would not only lead to long-term changes in 
stress hormone system regulation, but also to alterations of neuronal 
circuits, as reflected by structural changes in the hippocampus, and 
other glucocorticoid receptor responsive systems, as reflected by global 
gene expression changes in the immune system, resulting in a higher 
risk for trauma-associated psychiatric, immune and metabolic disor-
ders in exposed adults. The fact that the interaction of FKBP5 geno-
type and early trauma can predispose an individual to both PTSD and 
depression indicates that this interaction is likely associated with stress 
sensitivity in general, crossing current diagnostic borders. Our find-
ings appear to be of particular relevance for the developing organism, 
as the effects on DNA methylation seemed to be restricted to exposure 
to childhood trauma and were not influenced by traumatic experi-
ences in adulthood or current cortisol levels, suggesting that there is a 
sensitive period in early development for these epigenetic effects. The 
importance of disinhibition of FKBP5 for mood and anxiety disorders 
is supported by rodent models showing that enhanced transcription of 
Fkbp5 in the amygdala is required for stress-, neuropsin- and EphB2-
dependent induction of anxiety-like behavior in mice34. In addition, 
stress responsiveness is impaired in Fkbp5 knockout animal35,36.
In our studies, we focused on adverse environmental exposures. 
It is, however, possible that the described polymorphisms define not 
only risk versus resilience, but possibly environmentally reactive 
versus less reactive individuals. This would imply that the so-called 
risk-allele carriers may also profit more from positive environmental 
change. Our results provide insight into the molecular mechanisms 
and consequences of this gene × environment interaction, facilitat-
ing a better understanding of the pathophysiology of stress-related 
psychiatric disorders by including genetic and environmental infor-
mation in the diagnosis, and potentially aiding in the development 
of new treatments targeting this mechanism.
METhODS
Methods and any associated references are available in the online 
version of the paper.
Accession numbers. Data from the microarray experiment are depo-
sited at the GEO repository, GSE42002.
Note: Supplementary information is available in the online version of the paper.
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Human samples. The initial patient cohort that we investigated is part of a larger 
study investigating the roles of genetic and environmental factors in predicting 
response to stressful life events in a predominantly African-American, highly 
traumatized, urban population of low socioeconomic status and now counts 
over 4,000 participants3,37–39. All procedures in this study were approved by the 
Institutional Review Boards of the Emory University School of Medicine and 
Grady Memorial Hospital. The samples for the replication study of 56 female sub-
jects were recruited as part of the larger Conte Center Study for the Psychobiology 
of Early-Life Trauma4,27. The study was approved by the Institutional Review 
Board of Emory University School of Medicine.
Psychometric instruments. PTSD symptomatology was assessed by the mPSS as 
described previously3. The CAPS was used to assess current and lifetime PTSD 
diagnosis3. BDI was used to assess depressed mood in all individuals with the 
21-item self report3. The CTQ was used as a continuous measure of childhood 
abuse and neglect in all individuals using the 28-item version of the CTQ40. For 
child abuse stratification, we used the subscales for sexual and physical abuse.
For the gene x environment interaction analyses, participants were dichot-
omized into two groups for each of the two categories of abuse (presence or 
absence of severe physical or sexual abuse according to CTQ). Cut-off scores of 
≥13 for sexual abuse and ≥13 for physical abuse were used to define exposure 
to severe abuse in each of the categorized subjects. Finally, we created a 3-level 
categorical composite variable across the two abuse types, grouping participants 
into those with no severe exposure to any childhood abuse (scores less than cut-
off for both types of abuse) and those with one or two exposures.
For the DNA methylation analyses, we divided participants into two groups 
for each of the three categories of abuse according to the presence or absence of 
moderate-to-severe physical, emotional or sexual abuse. Cut-off scores of ≥8 for 
sexual abuse, ≥13 for emotional abuse and ≥10 for physical abuse were used to 
define exposure to moderate to severe abuse in each of the categorized subjects. 
Finally, we created a categorical composite variable across the three abuse types, 
grouping participants into those with no moderate to severe exposure to any 
childhood abuse (scores less than cut-off for all types of abuse) and those with 
moderate to severe exposure to at least two types of abuse.
To allow for comparisons with previous studies3, we also used the TEI, which 
assesses lifetime history of trauma exposure to a range of traumatic events, includ-
ing childhood sexual and physical abuse, and was assessed in all individuals. The 
TEI child abuse variable was highly concordant with the categorizations using 
the CTQ. To summarize the level of exposure to trauma other than child abuse, 
we summed the total number of different types of non-child abuse trauma expo-
sure (TEI) reported by each subject. In this cohort, the different types of non–child 
abuse trauma were experience at an average of 22.6 ± 10.6 years (mean ± s.d.) 
of age, and we refer to this type of trauma as adult trauma.
dnA and RnA collection and extraction. For genotyping, DNA was extracted 
either from saliva (Oragene DNA, DNA Genotek) or whole blood as described 
previously for the Grady trauma project3, and from whole blood for the Conte center 
sample4. For pyrosequencing, genomic DNA was extracted from peripheral blood 
using the Gentra Puregene Blood Kit (Qiagen) as described previously18. DNA qual-
ity and quantity was assessed by a NanoDrop 2000 Spectrophotometer (Thermo 
Scientific) and Quant-iT Picogreen (Invitrogen). For peripheral blood mRNA, blood 
was drawn between 8:00 and 9:00 a.m. into Tempus RNA tubes (Applied Biosystems) 
and stored at –20 °C until RNA extraction. RNA was isolated using the Versagene 
kit (Gentra Systems) and quantified using the Nanophotometer, and quality checks 
were performed on the Agilent Bioanalyzer as described previously15.
genotyping. In the Grady trauma cohort, genotype of rs1360780 was evaluated 
using TaqMan SNP genotyping assays (Applied Biosystems) and Sequenom 
i-plex assays (Sequenom). For imputation of SNPs in the FKBP5 locus, we used 
genotypes from the Illumina OmniExpress array. In the Conte center cohort and 
the human hippocampal progenitor cell line, rs1360780 was evaluated using a 
TaqMan SNP genotyping assay3.
methylation analysis by bisulfite pyrosequencing. Methylation analysis by 
pyrosequencing of bisulfite-treated genomic DNA was performed by varionos-
tic GmbH (http://www.varionostic.de/). Genomic DNA was bisulfite converted 
using the EZ DNA Methylation Gold Kit (Zymo Research). Amplicons 
were generated from bisulfite DNA covering four intronic glucocorticoids- 
responsive elements, the CpG island around the TSS and one region upstream 
of the TSS (Fig. 4a and Supplementary Table 5). Sequencing was performed on 
the Q24 System with PyroMark Q24 analysis software in CpG (Qiagen). Data 
were analyzed using IBM SPSS Statistics, Version 17, as indicated. For subsequent 
analysis of DNA, we combined single CpG measures to bins, assuming that the 
DNA methylation around a transcription factor binding site is a functional unit. 
We divided the CpGs in the sequenced regions of FKBP5 into putative functional 
units according to their relative location to consensus GRE sites and chose the 
pyrosequencing primers accordingly. For example, in intron 7, three consensus 
GRE sites are described and their spatial relations to the CpG sites, the ampli-
con and sequenced regions are depicted in Supplementary Figure 2. CpGs in 
bin 1 are upstream of the 3 GREs, CpGs in bin 2 are surrounding and contained 
in the first consensus GRE, and the CpG in bin 3 is located in the third GRE. 
No CpGs were close to the second GRE.
Statistical methods. The gene × environment interaction results with the mPSS 
score as outcome were obtained from 1,963 African-American subjects with com-
plete FKBP5 genotype (rs1360780), CTQ and mPSS data and include individuals 
for which a gene × environment interaction had already been reported3, adding 
1,194 new individuals. In this analysis, we restricted ethnicity to African American 
only, whereas, in the previous study, individuals from other ethnic backgrounds 
were also included (less than 10%). In addition, 519 individuals were examined 
using the CAPS for lifetime PTSD diagnosis, with 368 individuals not included 
in the previous study3. Child abuse was defined using the categorical CTQ child 
abuse variable as described above. The FKBP5 SNP rs1360780 was analyzed using 
a risk allele carrier model. A general linear model was used to analyze the effects 
on mPSS total score, with the 3-level categorical CTQ sexual and physical abuse 
variable described above, rs1360780, their interaction term, as well as age and 
sex as predictors. Controlling for current depressive symptom severity (using 
the BDI) and total types of trauma exposure (TEI) did not change the results. 
A logistic regression was used to analyze the effects of lifetime PTSD as assessed 
by the CAPS, with the categorical CTQ child abuse variable, rs1360780, in a risk 
allele carrier model, their interaction term, as well as age and sex as predictors. 
For post hoc analysis, a contingency table in the two risk genotype carrier groups 
tested for effects of severity of child abuse (CTQ child abuse 3 level variable) on 
the presence of lifetime PTSD.
SNPs within 304-kb segment containing the FKBP5 locus (Chr6, 35553493–
35858276, version hg18) were selected from the OmniExpress Human SNP 
array (Illumina). Genotypes of these SNPs in 192 subjects from the Grady 
trauma projects were used to impute all variants in this locus detected in the 
1000 Genomes projects19 version release June 2010 in Yorubans using Impute 
v.2 (ref. 41). The proximity of SNPs to GREs was assessed using data presented 
previously20, as well as ChIP-Seq data for the region of imputation from the 
ENCODE project (http://genome.ucsc.edu/cgi-bin/hgTrackUi?g=wgEncodeTf
BindingSuper)42.
To examine DNA methylation of the FKBP5 locus, we selected an extreme 
subset of individuals from the Grady trauma project that had experienced at 
least both physical and sexual child abuse (N = 30) versus individuals that had 
not experienced any child abuse according to the TEI and CTQ and with no cur-
rent or lifetime PTSD or depression (N = 45). For data analysis, the percentage 
of DNA methylation was summed for CGs lying in the same sequencing primer 
(Fig. 4a,b and Supplementary Table 5) and used as the dependent variable in 
a general linear model that included trauma exposure, FKBP5 risk allele carrier 
status, their interaction term, and age and sex as predictors. We corrected for 
multiple testing using a Bonferroni correction for the seven CG bins as well as 
three tests (main effect for trauma status, FKBP5 risk allele carrier status and their 
interaction) with an alpha level of 0.05/21 (P < 0.0023) considered as statistically 
significant. In a second type of analysis, DNA methylation was correlated to the 
severity of child abuse using the log10-transformed continuous CTQ score in both 
the Grady Trauma Project and the Conte center project.
Bonferroni corrections were applied three times. First, when testing the DNA 
methylation in the seven CpG bins as outcome for main SNP effects, main envi-
ronment effect and interaction effects that is a total of 21 tests, second when test-
ing correlations between DNA methylation of bin 2 in intron 7 with volumetric 
magnetic resonance imaging data. Here the correction was for the four brain 
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regions (hippocampal head, body, tail and amygdala), but not each hemisphere, 
as the volumes across hemispheres are highly correlated. Third, we corrected 
for multiple testing when performing the pathway analyses for gene–expression 
where WikiPathways automatically corrects for the number of pathways tested. 
For these analyses, the corrected P values – Pcorr are presented.
RnA expression microarray and data analysis. RNA was amplified and hybrid-
ized onto Illumina HT-12 v3.0 arrays (Illumina) as described previously15. Raw 
microarray scan files from the Illumina BeadScan confocal laser scanner were 
exported using the Illumina Beadstudio program and loaded into R. The data 
were transformed and normalized using the variance stabilizing normalization43. 
A total of 15,877 probes passing the filter criteria of Illumina probe detection 
P < 0.01 in 5% of the individuals were used for subsequent analysis. The expression 
profiles were further normalized using ComBat, an empirical Bayes method for 
batch correction. Association analysis was performed using general linear models 
in R. The significance of association was estimated by two-tailed P values using 
the ANOVA F test. Correlations were calculated using the Pearson correlations 
functions in R. Pathway analysis was done using WebGestalt, a WikiPathways 
tool with Bonferroni correction for multiple testing. Global mRNA expression 
data were assessed in individuals from the Grady trauma project. From a total 
of 396 with mRNA expression measures, we selected cases (N = 55, physical 
and sexual abuse, mPSS score > 20) and controls (N = 74, no childhood abuse, 
mPSS < 20). These groups were subsequently stratified by FKBP5 genotype into 
risk allele carrier status. To determine which transcripts are regulated by gluco-
corticoids, we regressed the gene expression profiles against the baseline cortisol 
levels, adjusting for age and gender in all 129 subjects. A total of 1,627 transcripts 
were significantly regulated by glucocorticoids with P < 0.01. For these tran-
scripts, Pearson correlations between expression levels and baseline cortisol levels 
were calculated separately for cases and controls, further stratified by the FKBP5 
genotype carrier model (that is risk versus protective allele). The correlations 
between the two genotype groups were converted into z score differences for cases 
and controls. z score differences of <1.96 indicate significance at P = 0.05.
Reporter plasmid construction and transient transfection. The functional 
effect of differential methylation in intron 2 and intron 7 of FKBP5 was ana-
lyzed using a CpG-free luciferase reporter construct30 For intron 2, an 802-bp 
fragment containing the functional GRE was amplified from human genomic 
DNA with primer Intron2-F1 (containing a SpeI restriction site) and Intron2-
R1 (containing a SbfI restriction site). The reporter plasmid was digested with 
SpeI and PstI to release the original CMV enhancer fragment. The PCR ampli-
con was digested with SbfI and SpeI, purified and subsequently ligated into the 
SpeI and PstI sites of the vector. The amplicon contains the single-nucleotide 
polymorphism rs1360780, and constructs with the A/T risk allele and the G/C 
protective allele were established (Supplementary Table 5). For intron 7, a 515-bp 
fragment was amplified from human genomic DNA with primer Intron7-F1 
(containing a SpeI restriction site) and Intron7-R1 (containing a SbfI restriction 
site). The amplicon was ligated into the vector backbone as described above. 
All constructs were verified by sequencing (for additional information on primers 
and plasmids, see Supplementary Table 5). In vitro methylation of the reporter 
constructs by M.SssI CpG Methyltransferase (NEB) was carried out according to 
the manufacturer’s instructions. Successful methylation was confirmed by restric-
tion digest with PmlI (NEB), whereby linearization of the plasmids is blocked by 
CpG methylation. Methylated and unmethylated constructs were subsequently 
transfected into HEK-293 and HeLa cells (cultured in DMEM, supplemented 
with 10% fetal bovine serum, 1% sodium pyruvate and 1% antibiotic-antimycotic 
(vol/vol, Invitrogen)) using ExGen 500 in vitro Transfection Reagent (Fermentas) 
with Gaussia luciferase control vector for normalization of transfection efficacy. 
Firefly and Gaussia luciferase activity was measured in triplicates on a Tristar LB 
941 luminometer with automatic injection system (Berthold Technologies). HEK 
293 cells do not express the glucocorticoid receptor and are insensitive to dexa-
methasone stimulation. HeLa cells were transfected with the same constructs and 
successfully stimulated for 24 h with 50 nM dexamethasone. Data were analyzed 
using IBM SPSS Statistics, Version 17 as indicated.
TBP-dnA binding assay. To validate the protein DNA interaction of TBP with the 
genomic sequence at rs1360780, we used the EpiQuik General Protein-DNA Binding 
Assay Kit (P-2004, Epigentek) with 60-mer double-stranded oligonucleotide 
probes (Supplementary Table 5). The single-stranded oligonucleotides were 
resuspended in an equimolar concentration in 1× TE buffer and annealed by heat-
ing the mixture to 95 °C for 10 min and gradually cooling to 20 °C. The assay was 
performed according to the protocol of the manufacturer with 5 ng of purified 
recombinant TBP protein (PR-703, Jena Biosciences). We used antibody to TBP 
(ab818, 1 µg ml−1) and horseradish peroxidase–conjugated antibody to mouse 
(ab6820, 0.5 µg ml−1) from Abcam. Absorbance was measured at 450 nm at 20 °C 
on a Tecan Genios Pro microplate reader (Tecan). The assays were performed 
in triplicates. Background absorbance was subtracted from the measurement 
reading. Specificity of the interaction was tested according to the manufacturer’s 
protocol by addition of fivefold excess of non–biotin-labeled oligonucleotide to 
the reaction.
chromatin conformation capture. Chromatin conformation capture was car-
ried out as described previously44. We used two human lymphoblastoid cell lines 
obtained from healthy individuals homozygous for the FKBP5 SNP rs1360780 
GG and AA genotypes, respectively. Cells were cultured in RMPI with stable 
l-glutamine (Biochrom) supplemented with 10% fetal bovine serum and 1% 
antibiotic-antimycotic (Life Technologies). Crosslinking and cell lysis were per-
formed as described44. Nuclei were digested using 400 U of EcoRI. Subsequent 
re-ligation, de-crosslinking and purification were conducted according to the pro-
tocol. DNA samples were adjusted to 20 ng µl−1 using the Quant-iT dsDNA BR 
Assay Kit and the Qubit 1.0 Fluorometer (Life Technologies). Digestion efficiency 
and sample purity was assessed as described previously44. Primers were designed 
with an anchor primer in the fragment containing the TSS and in potential 
interacting fragments in and around introns 2 and 7 of FKBP5 using Primer3. 
Quantitative PCR was carried out using the Roche LightCycler 480 SYBR Green I 
Master on a Roche LC480 according to the instructions of the manufacturer 
(Roche). A 176-kb BAC clone (RP11-282I23) containing the complete FKBP5 
genomic sequence was obtained as a PCR control template from the BACPAC 
Resources Center of the Children’s Hospital Oakland Research Institute. The BAC 
clone was cut with EcoRI and re-ligated by T4 DNA ligase. All primer pairs were 
tested on a standard curve of the BAC control library and yielded PCR efficien-
cies >1.7. The presence of a single PCR product was confirmed by agarose gel 
electrophoresis and melting curve analysis. Cycling conditions were: 95 °C for 
5 min, 40 cycles of 95 °C for 15 s, 60 °C for 15 s, 72 °C for 20 s. Quantitative PCR 
data were normalized to GAPDH as a loading control and ERCC3 to control for 
interaction frequencies between samples. GAPDH cycling conditions were 95 °C 
for 5 min, 40 cycles of 95 °C for 10 s, 60 °C for 15 s, 72 °C for 20 s. ERCC3 cycling 
conditions were 95 °C for 5 min, 40 cycles of 95 °C for 15 s, 62 °C for 10 s, 72 °C 
for 25 s. Data analysis was carried out according to44 and is presented as relative 
crosslinking frequency. The primers used for the chromatin conformation capture 
interaction studies are listed in Supplementary Table 5.
cell culture of multipotent human hippocampal progenitor cells. Multipotent, 
human hippocampal progenitor cells (HPC03A/07, provided by ReNeuron) 
were grown in reduced modified media (RMM) as described previously29. 
To maintain proliferation, we added 10 ng ml−1 human bFGF (Peprotech), 
20 ng ml−1 human EGF (Peprotech) and 100 nM 4-hydroxytamoxifen (4-OHT; 
Sigma-Aldrich). To induce differentiation, HPC03A/07 cells were washed and 
cultured in RMM media without EGF, bFGF and 4-OHT. To assess changes in 
FKBP5 methylation status in proliferating human hippocampal progenitor cells, 
we cultured HPC03A/07 cells in 25-cm2 tissue culture flasks (Nunclon) for 72 h 
with 1 µM dexamethasone. To assess changes in FKBP5 methylation under 
differentiation conditions, we treated HPC03A/07 cells for 72 h under prolifera-
tion conditions in RMM media containing EGF, bFGF and 4-OHT. After the 
72-h proliferation phase, cells were washed twice for 15 min in RMM media 
without EGF, bFGF and 4-OHT, and subsequently cultured for another 7 d in 
media with 1 µM dexamethasone, but without growth factors. DNA was extracted 
using the Qiagen DNeasy Blood and Tissue kit (Qiagen) according to the 
manufacturer’s instructions. Data were analyzed using IBM SPSS Statistics, 
Version 17, as indicated.
Ex vivo glucocorticoid receptor sensitivity. To assess glucocorticoid receptor 
sensitivity, we used an ex vivo assay that estimates the degree of suppression 
of interleukin 6 secretion by the synthetic glucocorticoid, dexamethasone, in 
peripheral leukocytes, as described previously45,46.
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endocrine measures. Serum cortisol levels were assessed in samples drawn at the 
same time as the whole blood samples used for DNA methylation analysis. Blood 
draws were performed between 8:00 and 9:00 a.m. in the Grady trauma project 
and at 12 p.m. in the replication sample. Cortisol levels were measured using a 
standard radioimmunoassay kit (Diagnostic System Laboratories).
neuroimaging. Individuals were scanned in the Biomedical Imaging Technology 
Center at Emory University School of Medicine using a 3.0T Siemens Magnetom 
TIM Trio Scanner (Siemens Medical Solutions). We acquired high-resolution 
T1-weighted image scans with isotropic 1-mm resolution using a three-
 dimensional spoiled gradient echo acquisition protocol with sagittal volume exci-
tation to achieve contrast and resolution sufficient for structural analysis. All images 
were corrected for non-uniformity47, registered into standard stereotaxic space using 
the MNI template48, and normalized for signal intensity to harmonize gray-white 
matter contrast across subjects. For the amygdala and hippocampal segmentation, 
a segmentation protocol was employed with shown reliability and validity49.
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Supplementary Table 1 
IDs and positions of SNPs in high linkage disequilibirium with rs1360780, rs9296158, rs9470080 and rs3800373 (r-squared 0.4 or higher). 
# Name Position hg18 ObsHET HWpval MAF Alleles r-squared with risk haplotype SNPs 
1 rs4711420 35603788 0.542 0.3096 0.474 T:G 0.4-0.8 
2 rs6936515 35606241 0.516 0.7766 0.477 G:C 0.4-0.8 
3 rs9368872 35607623 0.516 0.7766 0.477 G:C 0.4-0.8 
4 rs9394303 35609923 0.505 1.0 0.482 G:A 0.4-0.8 
5 rs2103681 35611440 0.505 1.0 0.482 C:T 0.4-0.8 
6 rs7743152 35611553 0.505 1.0 0.482 A:G 0.4-0.8 
7 rs7759620 35614539 0.505 1.0 0.482 G:C 0.4-0.8 
8 rs7741320 35614543 0.505 1.0 0.482 T:C 0.4-0.8 
9 rs7741804 35614795 0.484 0.8088 0.461 T:C 0.4-0.8 
10 rs2894403 35615156 0.484 0.8088 0.461 T:C 0.4-0.8 
11 rs2395631 35615292 0.495 1.0 0.466 A:G 0.4-0.8 
12 rs11751447 35618099 0.484 0.8088 0.461 C:T 0.4-0.8 
13 rs9368874 35622058 0.516 0.786 0.482 T:C 0.4-0.8 
14 rs9394304 35622515 0.51 0.909 0.49 T:C 0.4-0.8 
15 rs11307625 35625231 0.49 0.9526 0.453 A:T 0.4-0.8 
16 rs9800506 35625367 0.474 0.2456 0.315 G:T 0.4-0.8 
17 rs873941 35632854 0.5 0.0939 0.328 T:A 0.4-0.8 
18 rs6911901 35636971 0.583 0.0226 0.453 C:G 0.4-0.8 
19 rs3800373 35650453 0.526 0.5663 0.477 A:C >= 0.8 
20 rs7757037 35656213 0.464 0.8976 0.346 G:A 0.4-0.8 
21 rs3798345 35670448 0.542 0.3222 0.484 C:T >= 0.8 
22 rs9296158 35675059 0.542 0.3167 0.479 A:G >= 0.8 
23 rs2395634 35675737 0.542 0.3222 0.484 G:A >= 0.8 
24 rs16878812 35677539 0.411 1.0 0.284 A:G 0.4-0.8 
25 rs11966198 35683633 0.396 0.3357 0.312 A:G 0.4-0.8 
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26 rs3777747 35686979 0.448 0.8633 0.354 A:G 0.4-0.8 
27 chr6:35693257 35693257 0.401 0.9536 0.284 A:C 0.4-0.8 
28 rs9368878 35693591 0.521 0.6901 0.495 C:T >= 0.8 
29 chr6:35696209 35696209 0.432 0.8393 0.299 C:T 0.4-0.8 
30 rs16879318 35698368 0.432 0.8393 0.299 A:C 0.4-0.8 
31 rs34356639 35700253 0.417 1.0 0.292 T:A 0.4-0.8 
32 rs7747121 35701960 0.432 0.8393 0.299 A:G 0.4-0.8 
33 rs10947562 35704889 0.427 0.4661 0.276 C:T 0.4-0.8 
34 rs16879378 35705680 0.432 0.8393 0.299 A:C 0.4-0.8 
35 rs3798347 35709753 0.526 0.5856 0.492 A:T >= 0.8 
36 rs1591365 35712084 0.542 0.2547 0.448 A:G >= 0.8 
37 chr6:35712673 35712673 0.417 1.0 0.292 T:A 0.4-0.8 
38 rs7751598 35713177 0.51 0.9126 0.495 A:G >= 0.8 
39 rs1360780 35715548 0.484 0.7587 0.482 C:T >= 0.8 
40 rs6902124 35718285 0.49 0.8753 0.479 A:C >= 0.8 
41 rs9380525 35741015 0.484 0.7677 0.477 G:C >= 0.8 
42 rs9368881 35742265 0.479 0.6649 0.474 A:G 0.4-0.8 
43 rs9348980 35747030 0.458 0.6866 0.391 T:A 0.4-0.8 
44 rs9470080 35754412 0.479 0.6649 0.474 T:C >= 0.8 
45 chr6:35759185 35759185 0.464 0.8179 0.341 C:G 0.4-0.8 
46 rs3800372 35763222 0.495 1.0 0.466 G:A >= 0.8 
47 rs9380526 35766304 0.484 0.7677 0.477 C:T >= 0.8 
48 rs6902321 35778584 0.51 0.1561 0.354 T:C 0.4-0.8 
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Supplementary Figure 1. Long-distance interaction of Glucocorticoid Responsive Elements in FKBP5 and suggested
epigenetic mechanism of trauma induced demethylation.
(a) FKBP5 mRNA transcription is induced by cortisol via a three-dimensional interaction and loop formation of 
predominantly distal enhancer regions harbouring GREs, that are located in the promoter region, intron 2, 5 and 7 
with the core promoter site. Only interactions confirmed by 3C are depicted by blue boxes. The GR as activating 
transcription factor is represented in light yellow (PolII = RNA Polymerase II). 
(b) When the acute stressor is over, a negative feedback mechanism via the GR leads to a normalization of cortisol 
levels in carriers of the G (protective) -allele of rs1360780 and in consequence less transcriptional effects on GR 
target genes, including FKBP5 (FKBP5 transcription is represented by green arrows). 
(c) The A (risk) -allele of rs1360780 confers a stronger interaction of intron 2 with the promoter region and is associated 
with an increased binding of TATA box binding protein (TBP, represented in red), potentially by formation of an 
additional TATA-box like sequence in intron 2. This leads to a stronger transcriptional induction by cortisol in carriers 
of the risk allele vs. carriers of the protective genotype as depicted in panel (a)  and indicated by the green arrow. In 
risk allele carriers, the initial rise in cortisol and GR activation leads to higher levels of FKBP5, which have been 
associated with an impaired negative feedback of the stress hormone axis and prolonged elevations of cortisol 
levels after a single stressor. 
(d) This long-lasting cortisol exposure then induces DNA demethylation around functional GREs in intron 7 (depicted by 
red ‘M’ circles). This further enhances the genetic predisposition for a stronger GR-induced transcription of FKBP5
(stronger GR activation in intron 7 represented by the red GR element), leading to changes in GR sensitivity. 
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Supplementary Table 2 
Primers for bisulfite pyrosequencing and genomic location of the regions investigated 
Amplicon name and 
genomic location (hg18) 
Amplicon 
primer 
(Bisulfit-
DNA), name  
Amplicon primer (Bisulfit-DNA), Sequence 5'-
3' 
Sequencing 
primer, name Sequencing primer, Sequence 5'-3' 
No. Of CpG 
dinucleotides 
interrogated 
     
 
P1 P1_F_MPI GTTGTTTTTGGAATTTAAGGTAATTG       
chr6:35,666,288-35,666,763 P1_R_MPI 
BIOTIN-
TCTCTTACCTCCAACACTACTACTAAAA       
Intron 7     P1_S1 AAGTATAAAAAAAAAATGGTTT   
      P1_S2 TGGAGTTATAGTGTAGGTTTT   
      P1_S3 GTTGATATATAGGAATAAAATAAGA 6 
P2 P2_F_MPI BIOTIN-ATTTAAAGGGGGAGGGA    
chr6:35,677,658-35,677,924 P2_R_MPI CCTTTTTTCCCCCCTAT    
Intron 5   P2_S1 TCCCCCCTATTTTAATC  
   P2_S2 ACTCCAATTTAAATAATATTTTAC 5 
P3 P3_F_MPI GGAAAAGTTGAGAATTATTGTATTG       
chr6:35,686,677-35,687,097 P3_R_MPI CAAAATATTCTACAAATTCCAATTAT       
Intron 5     P3_S1 GAGAATTATTGTATTGGAGG   
      P3_S2 TGTGTATTTTTGTTTAAGTTTT   
      P3_S3 TGGAGAGGGAAAGGAG 4 
P4 P4_F_MPI TGTATAGGTTTGTAGTTTTGGAGTAGT    
chr6:35,715,732-35,716,027 P4_R_MPI BIOTIN-CCTTTCTCAAATTCAATTTATTCAC    
Intron 2   P4_S1 TTTGGAGTAGTAGGTTAAA  
   P4_S2 TTTAGAATATATTTTTGTTTTTAAG 4 
P5 P5_F_MPI GTTTTGAATTATATTGAAGGGTATTT       
location according to P10 P5_R_MPI CAAAACTCCTTATACTCTTCTATTCTAA       
TSS     P5_S1 TGAATTATATTGAAGGGTATTTA   
      P5_S2 GGTTAGTTAATAGAAGAAAGTTATTT 15 
      
P6 P6_F_MPI GTTTTAGAATAGAAGAGTATAAGGAGTT    
location according to P10 P6_R_MPI ACCTAACCAAACTATAAAAAAAATAATA    
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TSS   P6_S1 AGAATAGAAGAGTATAAGGAGTTT  
   P6_S2 GATAGAGGAGATGAGGTTTTTTAA 25 
P7 P7_F_MPI GAGGAGGTAGGTGAAGG       
location according to P10 P7_R_MPI CCCCAAATAACAAATCC       
TSS     P7_S1 GGTTATTTAGTTATTATTTTTTTTAT   
      P7_S2 AAAGAGAAGTTTGGTTTT 39 
P8 P8_F_MPI BIOTIN-GGAGAGGGATTTGTTATTT    
location according to P10 P8_R_MPI CTACCTCAACTCCCACC    
TSS   P8_S1 CTCAACTCCCACCCC  
   P8_S2 CCTCCACCCCACTAC  
   P8_S3 CCCCCCCACCTCTCCC 43 
P9 P9_F_MPI GGGGTGGGAGTTGAGGTA       
location according to P10 P9_R_MPI BIOTIN-ACAACCCCCAAACCCTATAA       
TSS     P9_S1 GGTGGGAGTTGAGGTA   
      P9_S2 TTTATTTTAGTGGTTATG   
      P9_S3 TTTTTAGTTAGTTTAGTAGG 49 
P10 P10_F_MPI GATAGGAGGGGTAGTGTTTTTAGAGA    
P10_R_MPI BIOTIN-CAAAACCCCCCTTCCATAAA    
  P10_lower_S1 GGGTAGTGTTTTTAGAGAGA  
Amplicon P5 to P10 are 
located on chr6:35,763,522-
35,764,770 
  P10_lower_S2 AAGGGTAAGGGTTAGATA  
TSS   P10_lower_S3 GGGTTTTATTTGTATGGA 19 
      
GRE-3 GRE3-F-MPI GGTTGTAGGGAATTATGA       
chr6:35,798,260-35,798,490 GRE3-R-MPI BIOTIN-TAACCAAACAAAACAAAAATA       
      GRE3_S1_MPI GGGAATTATGAGGTTG   
      GRE3_S2_MPI TTTTTAGTGTTTATTAGAG 6 
      
      
    
Sum of all CGs interrogated 215 
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Supplementary Figure 2. Bin structure of FKBP5 intron 7.
FKBP5 intron 7 bins were selected according to their spatial and functional relationship to consensus GREs and 
the technological limitations of pyrosequencing. There are 3 consensus GRE bindings sites (sequences in bold 
and underlined) within the chosen 476 bp amplicon of intron 7 (primer position indicated as dashed arrows). 
Interrogated CpGs are highlighted in red/bold. Since pyrosequencing can only reliably generate short reads, we 
had to select three sequencing primers (see Supplementary Table 5) to cover the CpGs of interest (bold and red) 
and each high quality sequencing read is highlighted in yellow. The bin structure was thus determined by the 
relative position of the CGs to the consensus GREs as well the length limitation of the pyrosequencing reads. In 
intron 7 the CGs in bin 1 were upstream of all GREs, the 3 CGs of bin 2 are surrounding the first GRE and bin 3 
represents the CG within the third GRE.
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Supplementary Figure 3. FKBP5 x childhood abuse interaction on DNA methylation.
For statistical analysis CpGs are combined into bins of 1-3 CpGs with spatial and likely functional proximity. The 
analysis showed that FKBP5 DNA methylation in intronic regions is genotype and trauma dependent. Intron 7, 
bin 2 revealed significant trauma (F73,1 = 8.2, P = 0.006), genotype (F73,1 = 34.33, P < 0.001) and interaction 
between genotype and trauma effect (F73,1 = 31.01, Pcorr < 0.001, Bonferroni corrected for 7 CG bins and 3 tests 
(main effect of trauma, FKBP5 rs1360780 genotype and their interaction) (age and gender as covariates). A 
significant genotype effect (age and gender as covariates as above) was observed in intron 2, bin 2 (F70,1 = 
27.88, P < 0.001, no trauma or interactive effects) and intron 7, bin 3 (F73,1 = 26.39, P < 0.001, no trauma or 
interactive effects). For intron 2, bin 1 we observed no main trauma (P = 0.222) or genotype (P = 0.593) effect 
but the interaction revealed a nominal significant interaction (P = 0.006, not surviving Bonferroni correction for 
multiple testing, P = 0.126 for 21 tests). No other bins showed a significant effect of trauma, genotype or their 
interaction term. 
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Supplementary Table 3 
Correlation between Intron 7, Bin 2 methylation and CTQ scores, Grady and Conte cohort. The differences on correlation between CTQ sexual 
abuse in the Conte cohort and the Grady cohort are most likely caused by a differential traumatization of both cohorts with less sexual abuse in the 
Conte cohort (see also Table 1).  
Grady trauma prolect cohort 
          
       
 
FKBP5 risk allele 
carrier 
 
FKBP5 
protective 
allele carrier 
   
 
N=55  N=19 
   
       
 
Intron 7, Bin 2 
p 
value Intron 7, Bin 2 
p 
value 
Fisher z 
score p value (two tailed) 
CTQ total -0.646 <0.001 0.414 0.078 -4.23 <0.001 
Log CTQ total -0.690 <0.001 0.410 0.081 -4.49 <0.001 
Log CTQ physical abuse -0.641 <0.001 0.378 0.111 -4.05 <0.001 
Log CTQ sexual abuse -0.656 <0.001 0.599 0.007 -5.17 <0.001 
Log CTQ emotional abuse -0.685 <0.001 0.321 0.181 -4.1 <0.001 
       
       
 
partial 
correlation with 
age and gender   
partial 
correlation 
with age and 
gender     
 
df=51 
 
df=15 
   
       
 
Intron 7, Bin 2 
p 
value Intron 7, Bin 2 
p 
value 
  
CTQ total -0.678 <0.001 0.423 0.091   
Log CTQ total -0.718 <0.001 0.429 0.086   
Log CTQ physical abuse -0.700 <0.001 0.423 0.091   
Log CTQ sexual abuse -0.690 <0.001 0.570 0.017   
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Log CTQ emotional abuse -0.707 <0.001 0.377 0.136   
       
       
       
Conte Center cohort 
            
 
      
       
 
FKBP5 risk allele 
carrier 
 
FKBP5 
protective 
allele carrier 
   
 
N=33  N=23 
   
       
 
Intron 7, Bin 2 
p 
value Intron 7, Bin 2 
p 
value 
Fisher z 
score p value (two tailed) 
CTQ total -0.259 0.145 0.158 0.471 -1.47 0.141 
Log CTQ total -0.273 0.124 0.153 0.485 -1.5 0.133 
Log CTQ physical abuse -0.397 0.022 0.246 0.258 -2.33 0.019 
Log CTQ sexual abuse 0.118 0.514 0.305 0.922 -0.68 0.496 
Log CTQ emotional abuse -0.397 0.022 0.022 0.922 -1.53 0.126 
       
       
 
partial 
correlation with 
age   
 
partial 
correlation 
with age  
   
 
df=30 
 
df=20 
   
       
 
Intron 7, Bin 2 
p 
value Intron 7, Bin 2 
p 
value 
  
CTQ total -0.274 0.128 0.197 0.379   
Log CTQ total -0.255 0.159 0.172 0.433   
Log CTQ physical abuse -0.411 0.019 0.243 0.276   
Log CTQ sexual abuse 0.121 0.508 0.324 0.141   
Log CTQ emotional abuse -0.394 0.025 0.016 0.944   
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Supplementary Figure 4. A single allele confers FKBP5 demethylation in response to childhood abuse.
The correlation of the trauma exposure (overall (a) and subsequently divided into sexual, physical and 
emotional abuse (b-d)) and DNA methylation in intron 7 for individuals of the Grady cohort separated for the 
homozygous risk (AA), heterozygous (AG) and homozygous protective (GG) genotype. The panels above show 
that heterozygous individuals show a response similar to homozygous risk carriers, suggesting that a single 
allele conferring increased FKBP5 transcription would already lead to an enhanced cortisol response to stress 
and thus similar demethylation in homozygous and heterozygous risk allele carriers. 
a
c
b
d
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Supplementary Figure 5. FKBP5 methylation and adult trauma.
Absence of correlation of the types of adult trauma experience with FKBP5 intron 7 bin 2 methylation in both risk 
allele carriers (a) with (R = 0.202, P = 0.933, N = 20) and (b) without (R = 0.018, P = 0.917, N = 35) child abuse. 
a b
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Supplementary Figure 6. FKBP5 and current cortisol levels. 
Absence of correlation of baseline cortisol levels with mean % DNA methylation in intron 7, bin 2. Baseline cortisol 
levels in the Grady trauma project (a) and the Conte replication cohort (b) are not correlated with mean % DNA 
methylation in intron 7, bin 2 (R = 0.083, P = 0.489, N = 72 and R = 0.069, P = 0.603, N = 59, respectively). 
a
b
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Supplementary Table 4 
Cortisol x transcript correlation for Grady Trauma Project cohort, cases  
Illumina HT v3 
Probe NID Gene Symbol 
Correlation of 
transcript 
expression 
with baseline 
cortisol, p-
value 
Pearson 
correlation of 
transcript 
expression with 
baseline cortisol 
in cases risk 
genotype, r-
score 
Pearson 
correlation of 
transcript 
expression with 
baseline cortisol 
in cases 
protective 
genotype, r-
score 
Fisher z 
score 
between 
genotypes in 
cases 
ILMN_1670723 MSL3L1 2,00E-004 -0,15 0,87 3,402 
ILMN_2326591 ANXA6 8,57E-003 0,11 -0,87 3,272 
ILMN_1780898 PRKCH 1,37E-003 -0,33 -0,94 3,203 
ILMN_2380698 DSTN 6,65E-003 0,06 -0,87 3,148 
ILMN_1713156 MSL3L1 1,54E-004 -0,07 0,86 3,088 
ILMN_2415529 CDK5RAP2 1,61E-003 -0,21 0,81 3,029 
ILMN_1695025 CD2 8,89E-003 -0,21 -0,90 2,894 
ILMN_1787461 RUNX3 1,62E-003 -0,43 -0,94 2,888 
ILMN_2387285 MSL3L1 2,95E-003 -0,16 0,80 2,859 
ILMN_1736806 PAG1 1,52E-003 -0,15 0,79 2,785 
ILMN_1748283 PIM2 7,94E-003 -0,25 0,75 2,773 
ILMN_1736026 MMP8 1,53E-005 0,07 0,86 2,719 
ILMN_1681301 AIM2 1,45E-003 -0,24 0,74 2,708 
ILMN_1688279 PVRIG 3,27E-003 -0,11 -0,86 2,697 
ILMN_2404539 C20orf30 4,47E-003 0,05 -0,81 2,686 
ILMN_2056479 TXNL2 5,74E-003 0,17 -0,76 2,648 
ILMN_1813671 SLC25A1 1,01E-003 -0,24 -0,89 2,637 
ILMN_1741755 TRIM29 3,76E-005 0,31 -0,67 2,589 
ILMN_1792092 ZCCHC8 3,84E-003 -0,58 0,45 2,581 
ILMN_1770824 ARHGAP4 5,29E-003 -0,42 0,60 2,576 
ILMN_1677920 LTF 4,92E-005 -0,06 0,79 2,572 
ILMN_1708041 PLEKHF1 3,28E-003 -0,31 -0,90 2,553 
ILMN_1660732 PPP2R2B 8,79E-003 -0,12 -0,84 2,519 
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ILMN_1699496 PHF21A 3,25E-004 0,19 0,86 2,517 
ILMN_1703123 AXUD1 8,84E-005 -0,03 0,79 2,465 
ILMN_1692572 KIF27 5,49E-003 0,67 -0,27 2,453 
ILMN_2072178 ECHDC3 3,88E-010 0,31 -0,64 2,441 
ILMN_1703316 LOC255783 2,50E-003 0,16 0,84 2,421 
ILMN_1703697 LANCL1 2,54E-004 -0,15 -0,84 2,407 
ILMN_2307598 SLC37A3 1,03E-003 0,02 0,79 2,399 
ILMN_1708934 ADM 8,48E-003 0,09 0,82 2,396 
ILMN_1852022 KIAA1881 5,16E-004 0,29 0,87 2,366 
ILMN_1699991 LCK 3,45E-004 -0,19 -0,84 2,358 
ILMN_1753342 SAT1 1,27E-003 0,15 0,83 2,343 
ILMN_1791328 STK39 4,02E-003 -0,14 -0,83 2,337 
ILMN_1789596 ETV6 7,40E-003 -0,12 0,72 2,321 
ILMN_1754811 FBXO38 1,26E-003 0,18 0,83 2,303 
ILMN_1733627 NEDD4L 5,29E-003 -0,27 0,63 2,297 
ILMN_2316236 HOPX 2,05E-003 -0,28 -0,86 2,288 
ILMN_1798886 NUDT21 2,86E-003 -0,19 -0,83 2,286 
ILMN_2061405 NUP54 8,22E-003 -0,26 -0,85 2,281 
ILMN_1666713 LYPLA1 4,94E-003 -0,18 0,68 2,280 
ILMN_2405602 OSBPL1A 9,68E-008 0,15 0,82 2,268 
ILMN_1733421 PRKCQ 4,63E-003 -0,22 -0,84 2,267 
ILMN_1758418 TNFSF13B 5,41E-003 -0,15 0,69 2,265 
ILMN_1781184 MYBPC3 1,72E-003 0,15 0,82 2,252 
ILMN_1751958 NSUN5 1,53E-003 -0,51 0,41 2,246 
ILMN_1667371 SLA 5,73E-006 0,77 0,03 2,233 
ILMN_1907834  6,58E-008 0,55 -0,36 2,225 
ILMN_1739914 ZNF618 2,30E-003 0,32 -0,57 2,215 
ILMN_1784292 ANKMY2 1,52E-005 0,02 -0,74 2,212 
ILMN_1767193 CR1 1,10E-005 0,15 0,81 2,209 
ILMN_1705679 SAFB2 5,64E-003 -0,49 0,41 2,191 
ILMN_1812281 ARG1 4,18E-008 0,23 0,83 2,172 
ILMN_1770963 NAALADL1 3,92E-004 0,03 -0,73 2,170 
ILMN_1808566 TMEM180 4,06E-005 0,25 0,84 2,154 
ILMN_1789839 GTF3C1 6,28E-003 -0,14 -0,80 2,146 
ILMN_1706598 ACPL2 4,36E-003 -0,09 0,69 2,144 
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ILMN_2215355 LOC400499 2,02E-003 0,14 0,80 2,143 
ILMN_1688034 COIL 6,12E-004 -0,28 -0,84 2,101 
ILMN_1784287 TGFBR3 4,10E-004 -0,41 -0,88 2,096 
ILMN_1737157 GRAMD1A 5,34E-004 0,21 0,81 2,085 
ILMN_1669447 PYHIN1 5,63E-003 -0,46 -0,89 2,083 
ILMN_1661461 LOC283547 1,82E-003 0,51 -0,35 2,076 
ILMN_1775569 CRISP2 3,91E-003 0,43 -0,43 2,064 
ILMN_1796146 EIF4E3 1,32E-003 -0,05 0,69 2,055 
ILMN_1701837 KLHL2 8,44E-003 0,63 -0,17 2,054 
ILMN_2051232 SDHA 1,05E-003 -0,25 -0,82 2,043 
ILMN_2207291 IFNG 5,50E-003 0,07 -0,68 2,042 
ILMN_1801307 TNFSF10 8,50E-003 -0,05 0,69 2,029 
ILMN_2377109 LCK 1,60E-003 -0,04 -0,73 2,020 
ILMN_1765880 C16orf57 7,16E-004 0,33 0,84 2,015 
ILMN_1666902 GPR114 8,18E-004 -0,31 -0,84 2,002 
ILMN_1701731 AKR1B1 2,38E-004 -0,19 -0,79 2,000 
ILMN_1660976 LOC653204 2,00E-003 -0,20 0,59 1,984 
ILMN_1764431 COPS6 5,23E-004 -0,15 -0,77 1,972 
 
Cortisol x transcript correlation for Grady Trauma Project cohort, controls 
Illumina HT v3 
Probe NID Gene Symbol 
Correlation of 
transcript 
expression 
with baseline 
cortisol, p-
value 
Pearson 
correlation of 
transcript 
expression with 
baseline cortisol 
in controls risk 
genotype, r-
score 
Pearson 
correlation of 
transcript 
expression with 
baseline cortisol 
in controls 
protective 
genotype, r-
score 
Fisher z 
score 
between 
genotypes in 
controls 
ILMN_1656910 TRIM6 3,46E-003 0,01 0,80 3,306 
ILMN_1697268 EMILIN2 2,24E-003 -0,13 0,73 3,217 
ILMN_1743570 CEACAM3 6,09E-003 0,19 0,84 3,124 
ILMN_2404625 LAT 1,99E-004 -0,20 -0,84 3,093 
ILMN_1783500 HOXD12 2,88E-005 0,34 0,87 2,973 
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ILMN_1654685 MCTP1 5,37E-004 0,19 0,82 2,929 
ILMN_1788540 LOC732075 6,23E-003 0,42 -0,45 2,831 
ILMN_1808979 CLEC4D 1,00E-003 0,26 0,83 2,800 
ILMN_2231985 STCH 7,10E-003 0,38 -0,47 2,764 
ILMN_2371055 EFNA1 5,33E-003 0,44 -0,38 2,649 
ILMN_1871311  6,06E-003 0,36 -0,45 2,616 
ILMN_2326512 CASP1 2,30E-003 0,09 0,74 2,612 
ILMN_1810066 LOC650140 3,95E-003 0,38 -0,42 2,574 
ILMN_1717594 DKFZp761E198 1,60E-003 0,25 0,80 2,560 
ILMN_1722981 TLR5 7,90E-006 0,28 0,81 2,549 
ILMN_1780698 ZFYVE19 3,03E-004 -0,45 0,33 2,513 
ILMN_1758798 LOC728734 1,10E-003 -0,08 -0,72 2,513 
ILMN_1688423 FCER1A 2,12E-003 -0,45 0,31 2,445 
ILMN_1788002 MAPK14 5,72E-003 0,24 0,78 2,431 
ILMN_1804988 MOAP1 5,99E-003 -0,24 -0,78 2,431 
ILMN_1755954 CPEB3 1,47E-003 0,19 0,75 2,370 
ILMN_2339705 MED8 3,10E-003 -0,03 0,63 2,342 
ILMN_1678494 ZNF438 7,93E-003 0,20 0,75 2,339 
ILMN_1688098 TBC1D4 1,90E-003 -0,20 -0,75 2,339 
ILMN_1752526 RNF144B 1,06E-006 0,27 0,78 2,334 
ILMN_1771861 LOC642250 4,01E-003 0,50 -0,21 2,315 
ILMN_1859493  1,71E-003 0,42 -0,30 2,299 
ILMN_1719696 PLD1 2,07E-003 0,18 0,73 2,268 
ILMN_1778177 ZNF207 6,33E-003 -0,47 0,22 2,228 
ILMN_1747347 C17orf60 4,98E-003 -0,09 0,56 2,196 
ILMN_1707901 DHrs7B 9,34E-003 0,19 0,72 2,172 
ILMN_1872182  6,24E-003 0,41 -0,27 2,163 
ILMN_1881526  8,78E-004 -0,10 -0,67 2,157 
ILMN_1673933 LOC440341 2,22E-003 -0,05 -0,64 2,150 
ILMN_1678504 RHOT1 1,24E-004 0,20 0,72 2,140 
ILMN_1763322 CCR3 8,02E-003 -0,45 0,21 2,119 
ILMN_2412927 GMPPB 8,82E-003 -0,39 0,27 2,091 
ILMN_2323944 FAM110A 1,91E-004 -0,38 0,28 2,088 
ILMN_2140389 TMEM185A 9,21E-003 -0,16 -0,69 2,085 
ILMN_1718207 SETDB1 7,75E-003 -0,44 0,21 2,081 
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ILMN_1678766 DYNLT1 1,06E-003 0,20 0,71 2,078 
ILMN_1893129  4,19E-003 0,45 -0,19 2,056 
ILMN_1724668 REPS2 3,16E-004 0,29 0,75 2,048 
ILMN_1674394 C20orf3 1,98E-003 0,29 0,75 2,048 
ILMN_1769282 FRMD6 9,51E-003 0,41 -0,23 2,034 
ILMN_1709820 AOAH 7,76E-003 0,04 0,61 2,031 
ILMN_1752333 SLC35E1 9,49E-003 -0,06 -0,62 2,019 
ILMN_2397776 ASB6 3,92E-003 -0,11 -0,65 2,019 
ILMN_1732615 ASMTL 6,51E-004 -0,46 0,16 2,000 
ILMN_1752111 SMARCAL1 9,52E-003 -0,44 0,18 1,987 
ILMN_1785266 OFD1 8,37E-004 -0,04 -0,60 1,983 
ILMN_1794165 PGD 3,31E-003 0,23 0,71 1,983 
ILMN_1747205 JDP2 6,84E-003 0,25 0,72 1,981 
ILMN_2152028 LOC642452 5,08E-004 0,49 -0,11 1,963 
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Supplementary Figure 7. FKBP5 DNA methylation correlates with hippocampal volume. 
The left panel of the figure shows the 3D reconstruction of the right hippocampus with the three subregions – head 
(brown), body (yellow) and tail (purple) from the analyzed data set. The right panel shows that FKBP5 intron 7, bin 2 
mean methylation is negatively correlated with right hippocampal head volume (R = -0.484 P = 0.014, Bonferroni 
corrected, N = 34). For the left hippocampal head volume we also observed a negative correlation, however, it failed 
to reach nominal significance (R = –0.283, P = 0.105). These findings illustrate that early adverse experiences with 
subsequent enduring epigenetic changes in peripheral tissue specifically correlate with structural changes in the 
hippocampal head in the absence of more global correlations with brain morphology. 
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Supplementary Table 5 
Plasmids and primer used in this study 
Cloning of the reporter assay constucts 
   
 
    
Primer Sequence 5’ – 3’  
   
tctacACTAGTGCCCTTATTCTATAGCTGCAAGTC    
Intron2-F1 SpeI restriction site underlined    
tctacCCTGCAGGTCACTGCTCACTCGCTGA    
Intron2-R1 SbfI restriction site underlined    
tctacACTAGTGGGAGCCTCCAGAGTGAAAC    
Intron7-F1 SpeI restriction site underlined    
tctacCCTGCAGGCCAACACTGCTGCTGAAGAA    
Intron7-R1 SbfI restriction site underlined    
     
Plasmid Description 
   
pCpGL-CMV/EF1 CpG free reporter plasmid containing the basal EF-1α promoter, the 
CMV enhancer and an optimized luciferase gene. The plasmid was 
kindly provided by Maja Klug and Martin Rehli, University of 
Regensburg, Germany 
   
pCpGL-Int2A 802 bp fragment of FKBP5 Intron 2 ligated into pCpGL-
CMV(del)/EF1 containing the A allele of rs9296158 
   
pCpGL-Int2G 802 bp fragment of FKBP5 Intron 2 ligated into pCpGL-
CMV(del)/EF1 containing the G allele of rs9296158 
   
pCpGL-Int7 515 bp fragment of FKBP5 Intron 7 ligated into ppCpGL-
CMV(del)/EF1  
   
pCpGL-EF1 Control vector, containing the EF-1α promoter and luciferase gene 
without CMV enhancer element. The plasmid was kindly provided by 
Maja Klug and Martin Rehli, University of Regensburg, Germany 
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Oligonucleotides for the TATA-Box binding protein assay 
   
     
TBP-AF  
Biotin-
GCAGTAGCAAGTAAGAATTTTTGTTTTGTATAACTTTGCTTATGTGAAAGCCTTCTGTGC 
 
TBP-AR  Biotin-GCACAGAAGGCTTTCACATAAGCAAAGTTATACAAAACAAAAATTCTTACTTGCTACTGC 
     
TBP-GF  
Biotin-
GCAGTAGCAAGTAAGAATTTTTGTTTTGTGTAACTTTGCTTATGTGAAAGCCTTCTGTGC 
 
TBP-GR  Biotin-GCACAGAAGGCTTTCACATAAGCAAAGTTACACAAAACAAAAATTCTTACTTGCTACTGC 
     
 rs1360780 alleles are highlighted in bold, the putative TATA-box binding side is underlined  
     
Oligonucleotides for Chromatin Conformation Capture 
     
TSSanchor CTACAATTTCAGTTTCAAAAATTAAGCA 
   
Int2_prae1  TGCAGTGGTACCGTCATAGC 
   
Int2 GGCAAGCCAATGTAACCAAC 
   
Int2_post1 GGAGCTTGGAAAGAGCACAG 
   
Int2_post2  TTCTGCTCACCAAGATAACTGC 
   
Int7_prae1  AATCTCACGGGACCACTGTC 
   
Int7  TATTCTGGCAGCACCTACCC 
   
Int7_post1  CTGGGAAAGAAAGGGAGACC 
   
Int7_post2 TGGCAAAATCATTCCCACTT 
   
GAPDH-F1 TACTAGCGGTTTTACGGGCG 
   
GAPDH-R1  TCGAACAGGAGGAGCAGAGAGCGA 
   
ERCC3-F1 TCTTACCTGTTGGCCACTGACA 
   
ERCC3-F2  GTCTGACCTTGCCCAGTGATAG 
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Childhood maltreatment is likely to inﬂuence fundamental biolog-
ical processes and engrave long-lasting epigenetic marks, leading to
adverse health outcomes in adulthood. We aimed to elucidate the
impact of different early environment on disease-related genome-
wide gene expression and DNA methylation in peripheral blood
cells in patients with posttraumatic stress disorder (PTSD). Com-
pared with the same trauma-exposed controls (n = 108), gene-
expression proﬁles of PTSD patients with similar clinical symptoms
and matched adult trauma exposure but different childhood ad-
verse events (n = 32 and 29) were almost completely nonoverlap-
ping (98%). These differences on the level of individual transcripts
were paralleled by the enrichment of several distinct biological net-
works between the groups. Moreover, these gene-expression
changes were accompanied and likely mediated by changes in
DNA methylation in the same loci to a much larger proportion in
the childhood abuse (69%) vs. the non-child abuse-only group
(34%). This study is unique in providing genome-wide evidence
of distinct biological modiﬁcations in PTSD in the presence or ab-
sence of exposure to childhood abuse. The ﬁndings that nonover-
lapping biological pathways seem to be affected in the two PTSD
groups and that changes inDNAmethylation appear to have amuch
greater impact in the childhood-abuse group might reﬂect differ-
ences in the pathophysiology of PTSD, in dependence of exposure
to childhood maltreatment. These results contribute to a better un-
derstanding of the extent of inﬂuence of differences in trauma ex-
posure on pathophysiological processes in stress-related psychiatric
disorders and may have implications for personalized medicine.
epigenome | biomarkers | psychiatry | development
Childhood maltreatment is a complex problem that exerts anenormous impact on individuals, families, and society, and is
of great signiﬁcance for public health. Maltreatment during
childhood likely inﬂuences fundamental biological processes and
engraves long-lasting epigenetic marks, leading to adverse health
outcomes in adulthood (1). Exposure to adverse life events in
childhood has not only been linked to an increased susceptibility
for a number of psychiatric disorders, but also to cardiovascular
disease, diabetes, and chronic lung disease, possibly via long-term
inﬂuences on the immune system (2–9). This ﬁnding suggests that
early adverse experiences not only alter neurobiological systems
leading to an increased risk for psychiatric disorders, but may have
a long-lasting effect on a number of organ systems. Experience of
childhood abuse might inﬂuence these biological systems via epi-
genetic modiﬁcations conferring lifelong susceptibility to disease.
In fact, in humans, distinct epigenetic and gene-expression changes
have been observed in postmortem brains of suicide victims with
a history of childhood abuse compared with suicide victims without
a history of childhood abuse or control subjects (10).
Early life trauma is a strong risk factor for stress-related psy-
chiatric disorders, which themselves have been shown to be asso-
ciated with distinct changes in gene-expression and epigenetic
proﬁles, both in the brain as well as in peripheral tissues (11–13).
Posttraumatic stress disorder (PTSD) is one example of a common
and disabling disorder that occurs after exposure to potentially
life-threatening traumatic events during childhood and adulthood.
Individuals who experience early life stress have been shown to
develop PTSD in adulthood more often than individuals with no
history of early life stress (14–16), and are also more likely to be
exposed to traumatic events in adulthood (17, 18). PTSD and
other stress-related disorders can thus occur both in the presence
and absence of early life trauma.
It has been suggested that the impact of trauma can depend on
the type and timing of the adverse events, and this in turn deter-
mines downstream consequences, such as perturbation of bi-
ological pathways (19–21). Although individuals with PTSD with
or without a history of exposure to childhood maltreatment meet
diagnostic criteria for the same disorder, it is not clear whether
disease would be associated with similar biological modiﬁcations.
The central aim of this study was to search for evidence at the
genome-wide level of such distinct disease-related biological
modiﬁcations associated with the presence or absence of a his-
tory of childhood maltreatment. This goal was addressed by in-
terrogating the inﬂuence of early life trauma on gene-expression
and epigenetic signatures in immune cells occurring in patients
with PTSD as an example of a stress-related psychiatric disorder.
Results
In the present study we selected 169 individuals, all of whom had
experienced at least two types trauma other than childhood abuse.
Of these individuals, 108 had a trauma history but did not have
a life-time history of PTSD or current PTSD symptoms, and these
were thus considered trauma-exposed controls. Sixty-one indi-
viduals met criteria for current PTSD, of which 32 reported
a history of childhood maltreatment and 29 did not report child-
hood abuse. Clinical and epidemiological demographics of the
participants across the three investigated groups are depicted in
Table 1. To control for the observed signiﬁcant group differences
in age, sex, ethnicity, adult trauma severity, and substance abuse,
these variables were used as covariates in the association analyses.
Effects of Childhood Maltreatment on PTSD-Associated Transcriptional
Proﬁles. To test for gene-expression differences between individ-
uals with PTSD and trauma-exposed controls, linear regression
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models were built to assess the inﬂuence of the case status on ex-
pression proﬁles. A total of 303 transcripts were differentially
expressed between PTSD individuals with child abuse vs. controls,
and 244 transcripts were differentially expressed between PTSD
individuals without child abuse vs. controls after corrections for
multiple testing (adjusted P < 0.05) (Fig. 1 and Dataset S1). An
overlap of only 14 transcripts was observed (2%), indicating
distinct biomarker proﬁles in PTSD in the presence or absence
of child abuse. This overlap is no more than expected by random
chance (Fisher’s exact P value = 0.095). Post hoc analysis identi-
ﬁed that only 4% of the differentially expressed transcripts might
be confounded by lifetime PTSD treatment and only 1.5% of the
transcripts might be confounded by different proportions of
immune cells types, suggesting that these factors are not major
confounds in the current analysis (Dataset S1). Among the dif-
ferentially expressed transcripts, we successfully validated the gene-
expression changes in the corresponding groups by using quantitative
PCR (qPCR) in ﬁve of ﬁve tested transcripts (Dataset S2).
Correlation of Gene-Expression Differences with DNA Methylation
Changes. Childhood maltreatment has an inﬂuence on biological
processes via epigenetic modiﬁcations (22). To identify if the
above gene-expression changes were correlated with DNA meth-
ylation differences in loci encoding these transcripts, we investigated
DNA methylation proﬁles of the transcripts differentially regulated
in either of the PTSD case groups versus controls (n = 547) using
the Illumina 450 k HumanMethylation array. Transcripts with at
least one CpG within their respective gene locus on the Illumina
HumanMethylation 450 k array (n = 304) were assessed for
methylation differences in the same subjects tested for gene-
expression differences. Although at least one signiﬁcantly differ-
entially methylated CpG site was identiﬁed in 69.3% of transcripts
unique to PTSD cases with child abuse, only 33.6% of transcripts
unique to PTSD cases without child abuse also showed differences
on the DNA methylation level for at least one CpG after correction
for multiple testing. This difference was even more accentuated
in transcripts for which the locus showed signiﬁcant differences in
DNA methylation in ﬁve or more CpGs; here, 11.7% of the tran-
scripts showed such matching epigenetic differences in the PTSD
child abuse group, but this was only the case for 0.8% of the tran-
scripts from the PTSD non-child abuse-only group (Fig. 2 A and B,
and Dataset S3). DNA methylation results were validated for seven
CpG sites in two distinct loci using an independent method, the
Sequenom EpiTYPER (Dataset S4).
The relation between DNA methylation and gene expression
is complex. In line with other studies (23, 24), we observe negative
correlations of CpGs with gene expression close to the transcrip-
tion start sites and an increasing proportion of positive correlations
in proximal and distal regulatory sites (Fig. 2B and Dataset S5).
Compared with all tested CpGs within the differentially ex-
pressed transcripts, the CpGs that also show signiﬁcantly dif-
ferent methylation levels are more often located close to the 3′
UTR and in the body of the gene as well as in the shelves of the
CpG islands and the open sea. In addition, the vast majority of
these CpGs were hypermethylated in the case group (Fig. 2C). In
addition, even though the absolute differences in methylation
levels between the groups are small (for most less than 5%), the
direction of the differences in DNA methylation between the
case and the control groups agrees to a large extent (73% for
individual CpGs and 94% at the locus level) with the observed
group differences in gene expression (see Fig. 3 and Dataset S5
for more detail).
These results indicate that changes in gene expression are more
often associated with changes in DNA methylation in PTSD oc-
curring after child abuse than PTSD occurring in the absence of
child abuse, and that these changes in DNA methylation may in-
deed mediate the observed gene-expression changes.
Table 1. Distribution and comparisons of demographic and clinical variables of the samples included in the study
Sample
Demographics Group comparisons
Controls
(n = 108)
PTSD + child
abuse (n = 32)
PTSD no
child abuse
(n = 29)
P value P value P value
Controls ∼ PTSD +
child abuse
Controls ∼ PTSD
no child abuse
PTSD + child
abuse ∼ PTSD no
child abuse
Age – mean (SD) 44.23 (1.2) 39.56 (1.8) 43.69 (2.0) 0.059 0.044 0.134
Sex
Men 30 (27.8%) 5 (15.6%) 13 (44.8%) 0.244 0.113 0.023
Women 78 (72.25%) 27 (84.4%) 16 (55.2%)
Ethnicity
African American 101 (93.5%) 24 (75%) 25 (86.2%) 0.006 0.245 0.343
Other 7 (6.5%) 8 (25%) 4 (13.8%)
PSS – mean (SD) 3.49 (0.32) 35.06 (1.2) 29.83 (1.7) 1.89 × 10−72 1.14 × 10−52 0.011
CAPS current – mean (SD) 26.19 (3.3) 112.73 (9.8) 79.71 (10.2) 1.68 × 10−17 4.46 × 10−9 0.054
PTSD diagnosis
No 108 (100%) 0 0 2.59 × 10−32 1.4 × 10−26 1
Yes 0 32 (100%) 29 (100%)
BDI mean (SD) 8.08 (0.7) 30.13 (2.3) 25.27 (2.1) 2.36 × 10−24 8.47 × 10−18 0.128
Child abuse (CTQ) – mean(SD) 34.35 (1.0) 76.23 (3.5) 37.24 (2.0) 4.69 × 10−32 0.206 5.15 × 10−9
No of types of child abuse
(moderate to severe)
None 75 (69.4%) 0 29 (100%) 1.19 × 10−21 0.317 2.54 × 10−13
One 21 (19.4%) 0 0
Two 12 (11.2%) 32 (100%) 0
Total types adult trauma
(TEI) – mean (SD)
4.63 (0.23) 7.91 (0.6) 6.49 (0.6) 4.69 × 10−9 0.005 0.154
Substance abuse current
No 103 (95.4%) 28 (87.5%) 25 (86.2%) 0.111 0.077 0.881
Yes 5 (4.6%) 4 (12.5%) 4 (13.8%)
PTSD treatment lifetime
No 108 (100%) 24 (72%) 24 (82.8%) 8.9 × 10−5 0.03 0.352
Yes 0 8 (28%) 4 (17.2%)
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Enrichment of Biological Processes Among Differentially Expressed
Transcripts. As we observed differences in gene-expression pro-
ﬁles and epigenetic marks in PTSD occurring in the presence or
absence of childhood maltreatment, we next sought to better
comprehend how the transcripts interacted with each other. We
built subnetworks from the transcript relationships using a mod-
iﬁed gene-set enrichment analysis to identify overrepresented
networks in Ariadne Pathway Studio 8.0.
Although functional annotation revealed overlapping pathways
between the groups, such as cell survival, cell development, cell
migration, cell adhesion, T-cell activation, and immunity net-
works, several nonoverlapping networks were observed between
the groups. The most notable differences included the enrichment
of the central nervous system development and tolerance induction
pathways in the PTSD group with child abuse and the apoptosis
and growth rate networks in the PTSD group without child abuse
(Fig. S1 and Dataset S6).
Interestingly, despite the completely divergent transcripts
differentially expressed between the two groups, several over-
lapping networks were identiﬁed, suggesting a possible common
downstream effect of disease in blood cells.
Discussion
The objective of this study was to interrogate biomarker proﬁles
at the level of gene expression and DNA methylation in individuals
with PTSD with or without childhood abuse. We observed that
although robust gene-expression differences could be identiﬁed
for both PTSD groups compared with trauma-exposed controls,
the signiﬁcant changes hardly overlapped at the transcript-speciﬁc
level (2%) and only modestly (35%) at the biological pathway
level. In fact, the differentially expressed transcripts in each group
showed highly variable regulation and often the opposite pattern
in the respective other group (Fig. 1). Moreover, the extent of
epigenetic modiﬁcations (i.e., DNA methylation changes) con-
current with these gene-expression changes were up to 12-fold
higher in the childhood trauma-exposed PTSD group. Our results
imply that biological perturbations in individuals with PTSD who
have a history of childhood maltreatment may systematically and
meaningfully differ from those individuals with PTSD who do not
have a history of childhood maltreatment. These ﬁndings suggest
that taking into account exposure to childhood maltreatment is of
great importance in the search for and application of gene-
expression and DNA methylation signatures as biomarkers for
PTSD and other trauma-related disorders.
Despite the fact that the differentially expressed transcripts in
each PTSD group were distinct, similar cellular processes enriched
across both transcript groups, suggesting that these initially dif-
ferent changes could be associated with perturbation of common
downstream biological pathways. On the other hand, several
speciﬁc cellular processes were signiﬁcantly overrepresented
only in one of the PTSD groups, indicating that different bi-
ological pathways maybe altered in PTSD with or without
child abuse.
Long-term effects of child abuse may be mediated by epigenetic
modiﬁcations, especially DNA methylation changes (10, 25, 26).
The fact that we see up to 12 times as many differentially ex-
pressed transcripts also showing differences in DNA methylation
in the early abuse group seems consistent with this hypothesis and
may even suggest that the biological mechanisms leading to the
observed differences in gene expression are distinct depending on
the type of trauma exposure. Although the measured changes in
DNA methylation were small (98% were less than 5%), the fact
that we observe the expected directional association of DNA
methylation with gene expression for 94% of the loci (Fig. 3 and
Dataset S5), suggests that even such modest methylation differ-
ences could be of functional relevance. Comparison of DNA
methylation proﬁles between brain and blood has demonstrated
that interindividual DNAmethylation differences were the highest
in peripheral blood and, even though several DNA methylation
signatures were tissue-speciﬁc, interindividual variability patterns
were consistent across the tissues, suggesting that peripheral blood
might reﬂect at least some of the DNAmethylation changes in the
brain (27). Furthermore, a recent study in rhesus macaques
demonstrated that DNA methylation changes occurring in re-
sponse to early-life adversity were persistent into adulthood and
reﬂected in both prefrontal cortex and T cells (28). Our ﬁnding
that the top enriched biological process in the transcripts from
peripheral blood cells in PTSD with childhood trauma in central
nervous system development may be an indication of such po-
tential blood/brain overlap.
The analyses were performed using a common set of trauma-
exposed controls, not matched by exposure to childhood mal-
treatment. This approach allowed identifying distinct biomarker
proﬁles between the two case groups. The use of two distinct but
trauma-matched controls groups would make it more difﬁcult to
determine if the differences originate in the case or the control
groups. We acknowledge that this approach has limitations and
therefore performed a post hoc analysis using matched controls
with or without child abuse and did not see any differences in the
percentage of overlap in differentially expressed genes (Dataset
S7) between the two PTSD case group comparisons, indicating
that these results are not likely confounded by the study design.
Furthermore, comparisons of the transcripts deﬁning the signa-
ture of child abuse [by (i) direct comparison within PTSD cases
and (ii) comparison of individuals with and without child abuse
using the whole sample] with transcripts signiﬁcantly different
between any of the two PTSD case groups and controls showed a
minimal overlap (0.7%), suggesting that the gene-expression
signature of PTSD with and without child abuse is distinct from
the signature of child abuse within PTSD cases (Dataset S7).
Another potential confound of these results is the possibility
that the observed gene-expression and DNA methylation proﬁles
are only a reﬂection of differences in peripheral blood cell types.
Comparison with transcripts correlated with the relative amount
of the main immune cells subtypes (CD15–CD16, CD14, CD4,
and CD8) revealed that only up to 1.5% of the transcripts might
be confounded by differential cell counts. The possibility of the
Fig. 1. Inﬂuence of child abuse on gene expression proﬁles in peripheral
blood in PTSD. (A) Venn diagram representing the overlap of transcripts
signiﬁcantly differentially regulated between individuals with PTSD and
child abuse vs. trauma-exposed controls and individuals with PTSD without
child abuse vs. trauma-exposed controls. (B) Heatmap of differentially
expressed transcripts. Gene-expression fold-changes in comparison with the
controls is depicted. Up-regulation is depicted in magenta and down-regu-
lation is depicted in bright green.
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impact of other speciﬁc immune-cell subtypes, not measured in
our analysis can, however, not be excluded. Furthermore, be-
cause the gene-expression levels and methylation patterns were
only measured at one time-point, it is difﬁcult conclude whether
the expression and methylation changes are indeed the direct
consequence of exposure to child abuse per se or a reﬂection of
other factors changed by the response to child abuse or related to
the disease itself.
To the best of our knowledge, this genome-wide study as-
sessing the inﬂuence of exposure to childhood maltreatment on
gene expression and DNA methylation proﬁles in peripheral
blood in PTSD is unique. Our ﬁndings are in line with a recent
study demonstrating that epigenetic alterations in the hippo-
campus among suicide completers with or without childhood
trauma were distinct (29), although this study did not explore
related changes in gene expression. These data provide further
evidence that there are substantial differences in disease-related
biological perturbations in the presence or absence of exposure to
maltreatment in childhood. The fact that several nonoverlapping
biological pathways seem to be affected in the two PTSD groups
and that changes in DNA methylation appear to have a much
greater impact in the childhood maltreatment group may indicate
differences in the pathophysiology of PTSD, in dependence of
exposure to type of trauma. This ﬁnding could not only have
implications for biomarker research for stress-related disorders
but may help to elucidate pathophysiological differences in de-
pendence of trauma exposure in immune disturbances often ac-
companying these disorders (3, 4, 30, 31). If these distinct changes
are not limited to peripheral blood cells but extend to other
organ systems, as indicated by some studies (27, 28, 32), they might
also aid in the search for disease mechanisms and therapeutic
intervention.
Materials and Methods
Samples. Participants in this study belonged to a larger study investigating the
contribution of genetic and environmental factors in PTSD (33). All study
procedures were approved by the institutional review boards of Emory
University School of Medicine and Grady Memorial Hospital and all subjects
gave written informed consent to the study.
The 396 participants were selected from a larger study, which has been
described previously (34). Microarray gene-expression results had been
reported in a previous report (34) for a subset of these patients (n = 211). For
this study, we selected patients from a now expanded set of microarray
gene-expression results (adding 185 new samples with gene-expression
arrays to the previously reported ones) and we have now also added DNA
methylation array data for all 396 individuals.
35.3%
26.8%
8.5%
29.4%
41.92%
2%
13.97%
3.71%
21.18%
3.71%
12.7%
0.4%
%
 o
f t
es
te
d 
lo
ci
2 fold
5 fold
12 fold
0
10
20
30
40
50
60
70
PTSD + child abuse
PTSD no child abuse
≥ 1 signiﬁcant CpG ≥ 2 signiﬁcant CpGs ≥ 5 signiﬁcant CpGs
A
%
 o
f C
pG
s 
/ 
lo
ca

on
TSS1500 TSS200 5’UTR 3’UTR1st Exon Body
Correlaons + ve
Correlaons - ve
B
C
1st Exon
Body
5’UTR
3’UTR
TSS200
TSS1500
Island
Shores
Shelves
Others/
Open Sea
1st Exon
Body
5’UTR
3’UTR
TSS200
TSS1500
Island
Shores
Shelves
Others/
Open Sea
Neighborhood Locaon
Genomic Locaon Hyper Hypo
Hyper Hypo
0
20
40
60
80
100
Methylaon status of signiﬁcant CpGs 
in PTSD case group
10
30
50
70
90
Tested CpGs Signiﬁcant CpGs
n= 3958 CpGs n= 458 CpGs
2.5%
41%
12%
5.6%
19.2%
20%
52%
1.7%
13.8%
10.7%
6.8%
15%
44.3%
17.7%
13.1%
24.9%
3%
12.8%
1%
10.7%
3.1%
3.7%
13%
2%
1.5%
0.2%
49%
Fig. 2. Inﬂuence of child abuse on DNA methylation in peripheral blood in PTSD. (A) DNA methylation differences are more frequent in PTSD with child
abuse. The bar graph shows the percentage of transcripts differentially regulated in the two respective group comparisons having one or more, two or more,
or ﬁve or more differentially methylated CpGs in the locus. DNA methylation changes underlying the observed gene expression differences were 2- to 12-fold
higher in the PTSD with child abuse group compared with the PTSD with no child abuse group. (B) Correlations of DNAmethylation with gene expression. The
bar graph shows the percent of CpGs with positive vs. negative correlations with gene expression of the closest transcript in the whole sample stratiﬁed by
location with respect to the regulated gene. Inverse correlations close to the transcription start sites and an increasing proportion of positive correlations in
proximal and distal regulatory sites were observed. (C) Distribution of the tested (left panels) and signiﬁcant (middle panels) CpGs and direction of meth-
ylation across all differentially methylated CpGs in both groups. The right panels denote the relative distributions of all tested and signiﬁcant CpG sites with
respect to the closest gene and the CpG islands and the directions of methylation differences of the signiﬁcant CpGs. Of the signiﬁcant CpGs, 90% were
hypermethylated and 10% were hypomethylated in the PTSD case group with respect to the controls.
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Psychological Assessments. PTSD symptomatic scale and clinician administered PTSD
scale. The modiﬁed PTSD symptomatic scale (mPSS) was used as a measure of
PTSD symptoms (35). PSS frequency itemswere summed toobtain a continuous
measure, with values of above 20 considered as clinically signiﬁcant PTSD
symptoms. In addition, a categorical PTSD classiﬁcationwasmade by using the
scores of the B, C, and D clusters of the PSS. Individuals classiﬁed as having
PTSD needed to have clinically signiﬁcant symptoms in all three clusters, rep-
resenting intrusive, avoidance/numbing, and hyperarousal (36). The clinician-
administered PTSD scale (CAPS) was available for a subset of 349 of the 396
individuals (37). There was a signiﬁcant strong positive correlation between
PSS and current CAPS in this dataset (Pearson r = 0.69, P = 3.15 × 10−29). The
CAPS was also used to assess the presence or absence of lifetime PTSD.
Beck depression inventory. The Beck depression inventory (BDI) was adminis-
tered to measure current depression symptoms (38). Current depression and
PTSD symptoms were highly correlated (r = 0.653, P = 1.56 × 10−42). Di-
agnostic tests for variance inﬂation factor and tolerance revealed a variance
inﬂation factor of 1.72 and tolerance of 0.58, indicating no evidence for
multicollinearity between depressive and PTSD symptoms.
Substance abuse. As described previously (34), two self-report items were used
to assess for current alcohol and substance use-related problems.
Trauma-Exposure Measurements. Childhood trauma questionnaire. The childhood
trauma questionnaire (CTQ) was used as a measure of child abuse. The CTQ is
a consistent and stable self-report inventory assessing ﬁve types of childhood
trauma: sexual, physical, and emotional abuse, and emotional and physical
neglect (39). In accordance with prior research, we restricted our analyses to
the three abuse subscales only (40). As described previously, participants were
dichotomized into two groups for each of the three categories of abuse
(presence or absence of moderate to severe physical, sexual, or emotional
abuse). Finally, we created a composite variable across the three abuse types,
grouping participants into (i) those with no exposure to any childhood abuse
(scores less than cut-off for all three abuses), and (ii) those with moderate to
severe exposure to at least two types of childhood abuse (scores above cut-off
for at least two of the abuses).
Trauma events inventory. The trauma events inventory (TEI) is the primary
measure of non-child abuse trauma in this study (41). Total numbers of dif-
ferent types of trauma among the participants was summed up for each cat-
egory into a continuous variable. Although the TEI instrument also includes
exposure to non-child abuse traumatic events in childhood, the mean age of
exposure was 23.81 (0.70) y; hence, in the current study this refers to mostly
adult trauma.
Sample Selection. Of the sample of 396 described above, 169 individuals who
had experienced at least two types ofmoderate-to-severe childhood abuses or
at least two other types of traumas during their lifetime were included in the
analysis for this study. Of these, individuals with PSS ≤10 and moderate-
to-severe child abuse or two other types of traumas were selected as trauma-
exposed individuals with neither current nor a history of lifetime PTSD symp-
toms (trauma controls) (n = 108). From a total of 61 individuals with current
PTSD symptoms (PSS > 20 and signiﬁcant symptoms in all PTSD B, C, and D
clusters), we selected individuals (i) who had experienced at least two types of
moderate-to-severe childhood abuses (n = 32) and (ii) who had experienced at
least two other types of traumas but no child abuse (n = 29).
Fig. 3. Two examples of directional associations between DNAmethylation and gene-expression changes. This ﬁgure shows gene-expression and DNAmethylation
data for two genes,DLC1 (deleted in liver cancer 1 gene) and FSCN1 (fascin homolog 1, actin-bundling protein). The position of the signiﬁcant CpGs in relation to the
gene, CpG islands and other CpGs on the 450 k methylation array are on top of the series of diagrams for each gene (with DLC1 on top and FSCN1 on the bottom).
Below, we depict the difference in gene expression for the respective group comparison (Left), the correlation of methylation levels of a representative CpG in that
locus with the expression level of the gene in thewhole sample (Center), and the group differences in DNAmethylation of the signiﬁcant CpGs in the respective locus
(Right). These data illustrate that the direction of the differences in DNAmethylation and gene expression between the groups are as expected from the direction of
correlation between gene expression and DNA methylation in the overall sample. * indicates adjusted P value of less than or equal to 0.05.
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Statistical Analysis. Gene-expression data. Raw microarray scan ﬁles from Illu-
mina HT-12 v3.0 arrays (Illumina) were exported using the Illumina Beadstudio
program and loaded into R for downstream analysis (www.R-project.org).
Evaluation of the different microarray steps was done using the Illumina in-
ternal controls. Samples which were >5% SD were excluded. The data were
transformed and normalized using the variance stabilizing normalization
(42). A total of 15,877 probes passing the ﬁlter criteria of Illumina probe
detection P value of <0.01 in 5% of the individuals were used for subsequent
analysis. To correct for confounding as a result of batch effects, the data were
normalized using an empirical Bayes method for batch correction (43). Re-
producibility of the gene-expression data were assessed using six pairs of
technical replicates, yielding average Pearson correlations of 0.996. General
linear models were constructed by regressing the gene-expression proﬁles
against the PTSD group status and adjusting for sex, age, ethnicity, substance
abuse, and treatment. The signiﬁcance of association was estimated by two-
tailed P values using the ANOVA F test. Results were corrected for multiple
testing by 10,000 permutations using the permutation of regressor residuals
test (http://cran.r-project.org/web/packages/glmperm/index.html). Brieﬂy, the
general linear models for each transcript were built as described above and the
residuals of the regressions were permuted 10,000 times for each transcript
using the shufﬂe-Z method to obtain the empirical P values corrected for
multiple testing as described previously (34).
DNAmethylation data. Rawmethylation Beta values from the HumanMethylation
450k BeadChip (Illumina) were determined via the Illumina Beadstudio pro-
gram and loaded into R. Internal Illumina controls were used to assess the
qualityof staining, extension, hybridization, bisulﬁte conversion, and speciﬁcity.
Samples with probe detection call rates <90% and those with an average
intensity value of either <50% of the experiment-wide sample mean or
<2,000 arbitrary units (AU) were excluded from further analysis, allowing
163 samples for subsequent analysis. Unsupervised hierarchical clustering
was performed to identify extreme outliers and global trends in methylation.
One sample of male DNA was included on each BeadChip as a technical control
throughout the experiment and assessed for reproducibility, with average
Pearson correlation coefﬁcient of 0.993 across all replicates. Signals from
methylated (M) and unmethylated (U) bead types were used to calculate
a beta value as β = M/(U + M). Hybridization and chip batch effects were
accounted for using an empirical Bayes method (43). The samples were
quantile normalized and peak-corrected using the IMA package functions in R
(44, 45). Hybridization and chip batch effects were accounted for using an em-
pirical Bayes method (43). Methylation differences were calculated using gen-
eralized linearmodels in R by regressing the β-values against the PTSDgroup and
adjusting for age, sex, ethnicity, and substance abuse. Results were corrected for
multiple testing by 10,000 permutations using the permutation of regressor
residuals test (http://cran.r-project.org/web/packages/glmperm/index.html).
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SI Materials and Methods
RNA Extraction and Microarray Procedures. Whole blood was col-
lected between 8:00 and 9:00 AM under fasting conditions in
Tempus RNA tubes (Applied Biosystems). RNA was isolated
using the Versagene kit (Gentra Systems), quantiﬁed using the
Nanophotometer, and quality checks were performed on the
Agilent Bioanalyzer. Only samples with RNA integrity numbers
of ≥6 with clear 18S and 28S peaks on the Bioanalyzer were used
for ampliﬁcation, the average RNA integrity number was 7.87
(SD of 1.1). Next, 250 ng total RNA was reverse-transcribed and
biotin-labeled using the Ambion kit (AMIL1791; Applied Bio-
systems), 750 ng of cRNA were hybridized to Illumina HT-12
v3.0 arrays (Illumina) and incubated overnight for 16 h at 55 °C.
Arrays were washed, stained with Cy3 labeled streptavidin, dried
and scanned on the Illumina BeadScan confocal laser scanner.
The 450 kMethylation Array Procedures.GenomicDNAwas isolated
fromwholeblood stored inEDTAtubesusing theGentraPuregene
Kit (Qiagen). The DNA was quantiﬁed using the PicoGreen
(Invitrogen) and the quality was checked on an agarose gel. A total
of 1,000 ng DNAwas treated with sodium bisulﬁte using the Zymo
EZ-96 DNA Methylation Kit (Zymo Research) according to the
manufacturer’s protocol. Themethylation assay was performed on
4 μL bisulﬁte-converted genomic DNA at 50 ng/μL in accordance
with the Inﬁnium HDMethylation Assay protocol. The DNA was
ampliﬁed, fragmented and hybridized on the HumanMethylation
450k BeadChip (Illumina).
Separate Cohort Controls for Lymphocyte and Monocyte Cell Fractions.
Data from 54 individuals [36 men and 18 women, mean (SD)
age of 30 (1)] was used to interrogate potential correlations
between the relative lymphocyte and monocyte fraction in
whole blood and mRNA expression levels, while correcting
for age and sex (2). The amount of CD15–CD16+, CD14+, CD4+,
and CD8+ white blood cells was measured using FACS analysis
from whole blood drawn at the same time-point as a Tempus
RNA tube.
qPCR Procedures. cDNA was synthesized from 250 ng total RNA
using SuperScript II Reverse Transcriptase (Invitrogen). qPCR
was performed using the Universal Probe Library on the Roche
LightCycler 480 (Roche Applied Science). Assays were designed
using the Probe Finder Software (RocheApplied Science) and run
in duplicates according to the manufacturer protocol, except for
a total reaction volume of 10 μL. TBP was used as the endoge-
nous control gene. Primer sequences are provided in Dataset S8.
DNA Methylation Validation Using Sequenom’s EpiTYPER MassARRAY
System. A total of 11 CpGs spanning two amplicon regions
(SPON1 and TSPAN32) with a high density of CpGs were chosen
for validation. Sequencing was performed at varionostic. Ampli-
cons were designed using the SequenomEpiDESIGNER software.
All experimental procedures were performed under routine con-
ditions as outlined in the Sequenom Methylation Analysis Ap-
plication Note (www.sequenom.com/ﬁles/genetic-analysis-ﬁles/
dna-methylation-pdfs/8876-007-r02_epityper-app-note) using
the MassARRAY system from Sequenom. Robustness of the
assay was tested using a pair of technical replicates (correlations:
r = 0.998 for SPON1 and r = 0.983 for TSPAN32) for each and
three controls (positive, negative methylation, and negative tem-
plate control). Data analysis was performed by regressing the
methylation percentage against the PTSD group using general-
ized linear models and adjusting for age, sex, ethnicity and
substance abuse in R.
Pathway Analyses. The Ariadne Pathway Studio 8.0 (Ariadne
Genomics/Elsevier) was used to deduce relationships between
differentially expressed candidates using the Ariadne ResNet
database based on cellular processes criteria using subnetwork
enrichment analysis. Only categories with ≥ﬁve transcripts within
a cellular process and relationships with ≥two references were
considered were the analysis. Subnetwork enrichment analysis
applies the Mann–Whitney version of gene-set enrichment
analysis algorithm to each sub network to calculate P values.
Results were corrected for multiple testing using the Bonferroni
correction.
1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inﬂammation,
aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med
336(14):973–979.
2. Pace TW, et al. (2011) Increased peripheral NF-kappaB pathway activity in women
with childhood abuse-related posttraumatic stress disorder. Brain Behav Immun
25(1):6–13.
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Fig. S1. Distinct biological networks enriched in child abuse vs. no child abuse groups. Signiﬁcantly overrepresented cellular processes among transcripts in
PTSD (A) with or (B) without child abuse using Pathway Studio after Bonferroni corrections for multiple testing. Details of the subnetwork cellular processes
enrichment P values are shown in Dataset S3.
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Discussion 
 
Allele specific demethylation in FKBP5 
 
Gene by environment interaction studies investigate the risk for disease in response 
to an environmental factor moderated by the genetic disposition of the individual. 
So far, GxE studies have generated high hopes to advance our understanding of the 
pathophysiology of complex psychiatric disorders but are at the same time 
contestable due to the purely statistical approach and related limitations. 
Knowledge on the molecular mechanisms underlying GxE thus not only 
corroborates the statistical findings but may also generate innovative approaches 
towards prevention and therapy of psychiatric disorders caused by genetic and 
environmental factors.  
The GxE of FKBP5 with childhood abuse on various psychiatric phenotypes is an 
approach to investigate the combined effects of genetic variants in FKBP5 and 
childhood abuse exposure on disease risk. The genetic variants implicated in the 
GxE of FKBP5 and childhood abuse are in high linkage disequilibrium and 
distributed across the whole gene locus. Most of them are located in intronic 
regions and therefore possess no obvious relevant effects on protein structure and 
function. Hence it is difficult to determine the functional variant that mediates the 
biological effects. Extending previous findings from 2008, we increased the sample 
size and replicated the initial GxE of FKBP5 and childhood abuse on PTSD (Figure 5) 
and hypothesized that the functional genetic variant may be located in or close to 
known regulatory elements such as glucocorticoid response elements (GREs) 
mediating the effect of GR-activation on the transcriptional activation of FKBP5. In 
fact, we were able to show that a SNP in intron 2 of FKBP5 named rs1360780 
influences the enhancer properties of the adjacent GRE. By cloning the intron 2 
enhancer region with both alleles into a luciferase reporter vector, transfecting in 
HeLa cells and stimulating in-vitro with the GR agonist dexamethasone, we were 
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able to show that the SNP alters the transcriptional response of the enhancer 
element in response to GR-stimulation with the T (risk) allele leading to a stronger 
activation compared to the C (protective) allele. In addition, the T-allele may lead to 
an additional TATA-box like sequence structure and in-vitro binding assays of both 
alleles showed that in deed TATA-binding protein (TBP) bind stronger to the 
sequence harboring the T-allele compared to the C-allele. The presence of a 
potential TBP binding site in an enhancer region, about 50kb downstream of the 
transcription start site (TSS) lead to the question of if and how this region might 
interact with the TSS.  
 
Figure 5. Replication and extension of previous GxE of FKBP5 with childhood abuse on PTSD 
diagnosis in N=519. This GxE shows the interaction of FKBP5 with childhood abuse on PTSD 
symptom level. Of note, the presence of the so-called risk allele lead to an increased risk for PTSD in 
adulthood when individuals are exposed to severe sexual and physical trauma in childhood. In 
contrast, when “risk” allele carrier are not exposed to severe sexual and physical abuse, the “risk” 
allele confers a protective effect on PTSD risk. Thus, the designation of “risk” and “protective” alleles 
depend on the environmental context suggesting environmentally sensitive genetic variants in FKBP5 
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mediating environmental effects in both directions, for positive and negative outcomes. Figure taken 
from Klengel et al., Nat Neurosci., 2013 126.   
 
Studies using chromatin conformation capture (3C) and related techniques revealed 
that chromatin is a highly organized non-linear structure 127. This three-dimensional 
structure enables regulatory elements to form physical contact across long distances 
and even across chromosomes influencing gene regulation. More recently, it has 
been suggested that genetic variations may not only influence epigenetic pattern 
and transcription factor binding but also the three-dimensional structure of 
chromatin 128.  This form of long-range regulation has just been recognized to have a 
potential influence on psychiatric disorders also with the notion that most genetic 
variants found in recent association studies are located in intronic or intergenic 
regions 129.  
We subsequently performed 3C and showed that the downstream enhancer regions 
in intron 2 and intron 7 form a three-dimensional structure with the promoter region 
leading to a contact of the intron 2 GRE enhancer region with the promoter region 
in risk allele carriers but not in individuals harboring the protective genotype (Figure 
6). This loop formation and interaction of the enhancer with the promoter site thus 
also contributes to the stronger transcriptional activation of FKBP5 in risk allele 
carriers compared to protective genotype carriers. In summary, these experiments 
showed that rs1360780, a common SNP in high linkage disequilibrium with other 
SNPs implicated in several GxE studies might be the functional SNP that contributes 
to the genetic predisposition for an increased transcriptional response of FKBP5 in 
response to GR stimulation and stress, respectively.  
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Figure 6. Chromatin conformation capture (3C) of FKBP5 shows the interaction of intronic 
downstream regulatory elements with the transcription start site (TSS). The left panel shows the 
genomic locus of FKBP5 on top with the transcription start site represented by an arrow (minus 
strand). Horizontal lines represent EcoRI restriction sites on the genomic DNA. Below, the small 
arrows represent primer used in this experiment with grey boxes representing intron 2 (middle) and 
intron 7 (left) as well as the fragment representing the TSS (right). The lines represent relative 
crosslinking and therefore interaction frequencies with the solid line depicting the FKBP5 risk allele 
and the dashed line depicting the protective allele. The risk allele leads to an interaction of the intron 
7 as well as the intron 2 fragments with the TSS whereas the protective allele does not lead to an 
interaction of intron 2 with the TSS. The right panels represent the 3C results in a three-dimensional 
model. The physical interaction of intron 2 with the TSS in risk allele carrier may contribute to a 
stronger transcriptional activation of FKBP5 in response to GR activation. Figure adpted from Klengel 
et al., Nat Neurosci., 2013 126.   
 
We next asked the question if childhood abuse induces long-lasting epigenetic 
changes that might be associated with the risk to develop PTSD. We focused on 
DNA methylation as a potentially long-lasting epigenetic modification and 
established DNA methylation assays using bisulfite pyrosequencing and screened 
relevant regulatory regions in FKBP5 including the promoter region and known 
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functional GREs. The CpG island around the TSS and all GREs in intron 5 were found 
to be unmethylated. Significant DNA methylation above the technical limitation of 
bisulfite pyrosequencing of 5% was detected at GREs in the promoter, intron 2 and 
intron 7. We then investigated DNA methylation at these GREs in adult individuals 
recruited by the Grady Trauma Project, a cross-sectional study investigating 
childhood and adult trauma exposure with regard to stress-related disorders in an 
urban population characterized by a low socioeconomic status and high civilian 
trauma exposure in Atlanta, GA, USA 130. Individuals were stratified according to 
severe childhood trauma exposure and FKBP5 rs1360780 genotype. In summary, we 
were able to show demethylation in and around FKBP5 intron 7 GREs in trauma 
exposed risk allele carriers compared to trauma-exposed carriers of the protective 
genotype that retained a stable methylation pattern and were similar to non-trauma 
exposed individuals irrespective of their genotype (Figure 7). This result was 
replicated in an independent cohort. Therefore, this is the first example for a 
genotype dependent epigenetic modification in response to childhood trauma. It 
highlights that the long-lasting epigenetic effects of childhood abuse are genotype 
dependent paralleling previous statistical GxE.  
 
Figure 7. Genotype-dependent demethylation in intron 7 of FKBP5. Here, DNA methylation levels of  
6 CpG dinucleotides in and around functional GREs in intron 7 are depicted. Risk allele carriers 
exposed to childhood trauma (black columns) exhibit a demethylation at CpG 4, 5 and 6 compared 
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to individuals carrying the protective genotype (dark grey columns). Individuals not exposed to 
childhood trauma do not show significant methylation differences (white and light grey columns). 
Figure adapted from Klengel et al., Nat Neurosci., 2013 126. 
 
A major limitation of these results is the investigation of DNA methylation in 
peripheral blood, a heterogeneous tissue that may not be informative for 
pathophysiologic mechanisms in the brain. Therefore we controlled for white blood 
cell composition in our replication cohort and found no significant influence of 
different white blood cell subpopulations present. Moreover, we used a human 
hippocampal progenitor cell line heterozygous for rs1360780 in order to test the 
effect of in-vitro activation of the GR on intron 7 DNA methylation in neuronal cells. 
In fact, parallel to the observations in our human cohorts we found that GR 
activation by dexamethasone led to a demethylation in exactly the same CpGs in 
intron 7 in this cell culture model (Figure 8).  
 
Figure 8. Demethylation of FKBP5 intron 7 in a human hippocampal progenitor cell line. GR 
activation by dexamethasone, a synthetic GR agonist, leads to a demethylation in intron 7 CpG 4,5 
and 6 paralleling the effects of childhood trauma in FKBP5 risk allele carriers. This suggests that the 
activation of the GR by stress and subsequent demethylation may be present also in neuronal tissue. 
Figure adapted from Klengel et al., Nat Neurosci., 2013 126. 
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The observed demethylation was dependent on the timing of the treatment 
whereby treatment in the proliferation and differentiation phase led to a 
demethylation stable over time but treatment of differentiated neuronal/glial cells 
did not result in this demethylation again emphasizing the importance of the timing 
of the GR-activation and stress exposure. This will be discussed at the end of this 
section in more detail. The functional consequence of demethylation in and around 
intron 7 GREs is enhanced transcriptional activation as shown by in-vitro luciferase 
assays using methylated and unmethylated constructs (Figure 9a and 9b). Here, the 
unmethylated construct was more responsive to GR activation than the methylated 
construct presumably through stronger binding of the GR to the unmethylated 
sequence. Moreover, we also observed a negative correlation of DNA methylation in 
intron 7 with ex-vivo GR sensitivity (Figure 9c). Lower methylation in intron 7 will 
therefore result in higher FKBP5 transcription, a stronger feedback to the GR and 
thus a less sensitive GR with higher cortisol level over time, which is a risk factor for 
stress-related psychiatric disorders.   
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Figure 9. Demethylation of FKBP5 intron 7 leads to enhanced GR activation and GR resistance. (a) 
Schematic representation of the CpG-free luciferase vector harboring an intron 7 fragment containing 
3 GREs. (b) The unmethylated construct is more responsive to GR activation in HeLa cells by 
dexamethasone than the methylated construct. (c) DNA methylation in intron 7 is correlated with the 
ex-vivo GR sensitivity of human PBMCs with decreased DNA methylation leading to a less sensitive 
GR and thus GR resistance and elevated cortisol levels. Figure taken from Klengel et al., Nat 
Neurosci., 2013 126. 
 
Genome-wide epigenetic and transcriptional differences of childhood abuse and 
adult trauma 
 
Starting from initial candidate gene studies, technical improvements have quickly 
enabled researchers to investigate DNA methylation changes on a broader scale up 
to the genome-wide level. As shown by McGowan et al., the response of the 
methylome to maternal care in rats includes both hyper- and hypomethylated 
regions across a 6.5 million nucleotide DNA stretch 131. Similar, Provencal et al 
investigated the genome-wide promoter methylation profile of rhesus macaque 
blood and prefrontal cortex tissue in response to rearing conditions. Here, regional 
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increases and decreases in DNA methylation in response to rearing conditions were 
observed and the regions tended to cluster in gene families influencing gene 
expression of gene pathways despite a relatively low absolute methylation 
difference 132. In particular the study by Provencal provided more evidence on the 
similarities of environmentally induced epigenetic modifications between central 
neuronal tissue and peripheral tissue such as blood; suggesting a system wide and 
potentially common epigenetic response to stress.  
 
On a genome wide level, we were able to show that gene expression and DNA 
methylation in peripheral blood cells is distinct in PTSD patients exposed to 
childhood and adult trauma versus PTSD patients only exposed to adult trauma, 
both compared to a common trauma-exposed but PTSD negative control group 133. 
Moreover, the transcripts differentially expressed were non-overlapping and these 
differences were paralleled by DNA methylation changes (Figure 10).  
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Figure 10. Heat map of gene expression profiles between PTSD cases with childhood absue and 
adult trauma vs. trauma exposed controls (left) and PTSD cases with adult trauma only vs. trauma 
exposed controls (right). Individuals suffering from PTSD with and without exposure to childhood 
abuse present nearly non-overlapping gene expression profiles. Both groups were exposed to similar 
levels of adult trauma and compared to a common non-PTSD control group. Figure taken from 
Mehta et al., PNAS, 2013 133.   
 
Interestingly, DNA methylation changes were pronounced in PTSD cases with 
childhood abuse compared to PTSD cases with adult trauma only suggesting not 
only a distinct biological mechanism but also more long-lasting biological effects by 
epigenetic adaptations provoked by early life stress (Figure 11).  
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Figure 11. DNA methylation changes may contribute more in PTSD in response to childhood abuse 
than in PTSD in response to adult trauma. This graph shows the percentage of differentially 
expressed loci that harbor differentially methylated CpGs as detected by the Illumina 450k chip. 
Restricting the analysis to ≥1 CpG that is differentially methylated, a two fold enrichment in PTSD 
cases with childhood abuse over adult trauma only is detectable. This enrichment increases to twelve 
fold when restricting the analysis to ≥5 CpGs. Figure taken from Mehta et al., PNAS, 2013 133.  
 
It is still debatable whether or not epigenetic changes are the driver or the 
consequence of early life trauma induced gene expression changes. We addressed 
this question by correlating the DNA methylation changes we observed with gene 
expression profiles and found that for over 70% of the differentially methylated 
CpGs correlated with the expression of the corresponding transcript. Moreover, this 
correlation was strictly negative for CpGs around the transcription start site as 
expected but negative as well as positive for CpGs at other gene regions suggesting 
a role for DNA methylation at enhancer and repressor sites in response to childhood 
abuse fine-tuning the transcriptional response. Finally, case-control status of gene 
expression was paralleled by DNA methylation differences in over 90% of the 
transcripts investigated again suggesting a causal relationship between DNA 
methylation changes and gene expression of adjacent transcripts, although the 
majority of differentially methylated CpGs showed small absolute methylation 
differences below 5% suggesting that even small differences might be functional 
relevant. Surprisingly, CpGs that were associated with childhood abuse were more 
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likely to be located outside CpG dense regions such as CpG islands, arguing for an 
influence of childhood abuse on long-range regulatory elements.  
 
In summary, these data suggest that distinct biological mechanisms underlie the 
pathophysiology of PTSD of individuals exposed to childhood trauma compared to 
individuals that were exposed to adult trauma only and trigger the development of 
PTSD. These data also highlight the importance of the timing and the type of the 
stressor in determining the molecular pathways that are involved in disease 
development. These results also support the hypothesis that broad clinical entities 
such as PTSD or MDD might subsume disorders that present with a common clinical 
phenotype but originate from separate biological mechanisms. In turn, this would 
also argue not only for more sophisticated diagnostic but also therapeutic 
approaches using patient-specific therapies potentially reducing the high variation in 
treatment response and resistance by current common but less specific drugs and 
therapies 134.  
 
Timing of trauma is important 
 
Both studies included in this thesis highlight the fact that the timing of the stressor is 
an important variable influencing epigenetic, gene regulation and disease 
outcomes. This is not surprising because epigenetic regulation is highly controlled 
with regard to cell type specificity and timing. This is also reflected by the 
differential expression of epigenetic writers, readers and erasers such as the DNMT 
enzymes that are highly expressed in proliferating and developing cells but are also 
detectable in post-mitotic neuronal cell types. Therefore, the impact of any given 
environmental factor not only depends on the cell type that is affected but also on 
the developmental stage at which the effect occurs. Developmental stages such as 
early childhood or adolescence that include high cellular turnover and complex 
rearrangements of the epigenetic as well as functional profile of the cell are 
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therefore more prone to long-term epigenetic deregulation than more stable stages 
later in life. On an epidemiological level, the differential sensitivity to trauma is 
reflected by the differential impact of environmental stressors on the development 
of psychiatric disorders with a stronger influence of early life trauma compared to 
adult trauma exposure 135. 
Furthermore, animal studies such as the example of maternal care influencing GR 
methylation in rats argue for a time-dependent differential susceptibility. In contrast 
to the initial study by Weaver et al., Witzmann et al. subjected ten to twelve week 
old rats to a chronic stress paradigm. Although this paradigm lead to DNA 
methylation changes at the I7 promoter of the rat GR, the CpG site at the NGFI-A 
site remained unchanged emphasizing distinct effects of timing and type of the 
stressor on the epigenetic profile 136. Moreover, GR methylation in human post-
mortem brain tissue of childhood abused individuals suffering from MDD and MDD 
controls (without exposure to childhood abuse) was similar although the expression 
of NGFI-A and the 1F was altered 108,110. On the level of the FKBP5 GxE, this is 
paralleled by the strong impact of childhood abuse exposure but not adult trauma 
on the risk to develop PTSD 37. Moreover, we were able to show that the peripheral 
DNA methylation pattern in individuals suffering from PTSD is distinct in response to 
childhood abuse compared to adult trauma exposure 133.  
 
The use of peripheral tissue to investigate psychiatric disorders 
 
As already discussed, using peripheral tissue such as blood or saliva is a necessity 
especially in large human studies where neuronal tissue is not readily available. 
Whether or not this tissue actually contains relevant information on 
pathophysiological mechanisms in the brain or represents mere surrogate markers is 
controversial; however, studies including our work suggest similarities between 
blood and neuronal tissue 126,132,137. In particular this may be relevant for signaling 
cascades that are present in many tissues such as the GR activation by cortisol. In 
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addition, it remains elusive when the observed methylation changes get established 
or even if they represent existing risk factors since longitudinal studies investigating 
these marks over the lifetime are not available at the moment. As discussed already, 
DNA methylation is a binary readout with either a methylated or an unmethylated 
cytosine present at a certain genomic position. Though, intermediate methylation 
marks such as hydroxymethyl-, carboxyl- or formylcytosine may contribute to a more 
complex picture of DNA methylation. The partial methylation changes that we 
usually observe thus reflect either a specific subpopulation of cells that is most 
susceptible to certain environmental conditions or that the methylation pattern is 
not stably maintained across cell divisions. This applies for current gene expression 
studies as well, where the readout is not binary but clearly a composite 
measurement of a plethora of different cells in the given tissue. Single cell gene 
expression and epigenetic techniques will provide more insights into the cell-to-cell 
variability of transcription and regulation by epigenetic factors.   
 
Genetic and epigenetic interplay 
 
Future studies on the pathophysiology of psychiatric disorders need to address the 
complex interaction of several levels of genetic and environmental regulation. 
Although current genetic studies point towards a marginal contribution of main 
genetic effects to disease risk, the genome wide contribution of genetic variants 
needs to be further studied by increasing the power to reliably detect genetic 
effects. In addition to common polymorphisms, rare variants, but also structural 
variants such as insertions/deletions and larger copy number variations (CNVs) may 
contribute to the genetic predisposition. Although candidate GxE studies showed 
that genetic variants can modulate the impact of the environment, genome-wide 
GxE studies will provide a more comprehensive and certainly also more complex 
picture of GxE which is a statistical challenge given the amount of variables 
contributing to these interactions. In this regard, it will be important to characterize 
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the environmental factors contributing but also preventing psychiatric disorder in 
more detail. Here, epidemiological studies on detrimental and also protective 
environmental factors need to inform future GxE studies. Proximate to genetic and 
environmental measurements, knowledge on how these factors influence epigenetic 
conditions will be pivotal to understand the long-lasting influence of early life 
stressors and childhood abuse on psychiatric disorders. Here, we need to 
understand how the environment engages cellular signaling cascades and which cell 
types actually reflect the environmental exposure through its epigenetic profile, 
which is a complex network of DNA methylation, post-translational histone 
modification and non-coding RNAs. It remains an open question if epigenetic 
profiles such as DNA methylation reflect a predisposition or a consequence of 
environmental exposure. Longitudinal studies and animal models might help to 
understand the dynamics of this relationship. In addition, we have shown that 
genetic variation influences epigenetic profiles and their response to the 
environment on a candidate gene levels but similar effects on a genome wide level 
remain to be probed. Finally, to understand the consequence of genotype-specific, 
environmentally induced epigenetic changes, functional studies investigating the 
impact of those modifications on chromatic organization, gene expression and 
protein function are needed. 
 
Global versus specific changes in response to childhood abuse 
 
The studies included here make on one side a case for very specific epigenetic 
changes at one gene locus and on the other side argue for global changes in 
response to childhood trauma. It is unlikely that stress in the form of traumatic 
experiences will result in the modification of singular genes that in turn are 
responsible for the spectrum of observed molecular and behavioral changes. In fact, 
the response to stress is system wide including the immune system, the HPA axis, 
and the metabolic system and brain tissue. Thus, the impact of trauma is likely 
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genome wide, influencing multiple signaling cascades that result in specific 
phenotypes. Nonetheless, the effect of childhood abuse can induce very specific 
changes at even single CpG dinucleotides in FKBP5 that in turn influence 
transcription factor binding and result in modification of the HPA axis. Therefore, 
global as well as local epigenetic changes may play a role in the pathogenesis of 
stress-related disorders. However, the DNA methylation changes we and others 
have observed are not random. We have shown that DNA methylation at specific 
enhancer elements in FKBP5 influence the transcriptional activation of the gene. On 
a global level, childhood abuse induced pronounced alterations in DNA methylation 
of distal regulatory elements. It is important to mention however, that current 
approaches might not be able to detect DNA methylation in regions that are 
implicated in stress-related psychiatric disorders. For example, the FKBP5 GRE 
regions investigated in the first study are not covered by the widely used Illumina 
450k methylation array nor would they be covered by promoter tiling arrays or 
techniques such as reduced representative bisulfite sequencing (RRBS). In addition, 
although we gained substantial knowledge by using the Illumina 450k array, it 
covers only a fraction of the 28 million CpG sites in the genome and disregards non-
CpG methylation and other forms of DNA methylation such as hydroxymethylation.  
Aside from the question of where to look for DNA methylation changes or other 
epigenetic modifications in the genome, it also remains an open question of which 
cell type will be most informative on the level of disease marker but also to gain 
pathophysiological insight. Clearly, it would be interesting to investigate single 
neurons from different brain regions to look into the tissue and cell type that most 
likely mediates the effects of stress but this will remain difficult in larger human 
studies. On the other side, stress has been shown to affect multiple cell types on an 
organism wide level. Thus, the investigation of cell types not directly related to the 
brain but affected by common stress pathways may be beneficial. The investigation 
of heterogeneous tissue such as blood, saliva or even neuronal tissue leads to a 
composite readout over multiple different cell types that may cover true signals and 
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introduce confounders by changing cell type composition. This is especially relevant 
for psychiatric studies that so far have yielded rather small DNA methylation 
differences compared to other fields such as cancer. Future studies therefore may 
benefit from cell sorting and single cell techniques. 
 
Implications on study design in human epigenetic studies 
 
Most studies investigating DNA methylation in psychiatry to date are cross sectional. 
The advantage is that many individuals can be included in a short time frame and 
stratified by a case-control design. Nevertheless, this design does not enable us to 
follow epigenetic profiles over time and answer questions regarding the timing of 
the stressor and sequential molecular and behavioral alterations. Thus, longitudinal 
studies in populations at risk for psychiatric disorders are needed to get more 
insight in the dynamics of epigenetic changes in response to stress. Although stress 
is a major risk factor for PTSD and MDD and convincing evidence for epigenetic 
alterations in response to stress exist, positive environments can also influence 
disease development and thus need to be included. More recently, studies in 
rodents showed that aversive environmental conditions might induce effects in 
subsequent generations and suggest that apart from a behavioral transmission, 
epigenetic marks might be inherited through the gametes 138. At the moment it is 
unclear if this form of inheritance is relevant for human psychiatric disorders is but 
future studies may need to consider controlling for environmental exposure of the 
ancestral generation. In sum, future studies need to take a complex relationship of 
environmental exposure, genetic predisposition, dynamic epigenetic alterations and 
functional readout into account.  
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Can environmental epigenetics inform psychiatric therapy? 
 
The reversibility of epigenetic marks offers the possibility to modulate 
environmentally induced or disease associated epigenetic marks. Although first 
examples of epigenetic drugs influencing behavior in rodents were reported, it 
remains speculative at the moment if unidirectional drugs such as DNMT inhibitors 
would reverse the bidirectional changes in DNA methylation seen in early life stress 
models. In addition, not only is the direction of epigenetic marks in response to the 
environment highly variable but also the genomic location, thereby challenging the 
idea of an epigenetic drug restoring the complex epigenetic pattern in a given 
neuronal cell, while at the same time not damaging other cell types. Promising 
research tools that might be able to deliver induced epigenetic modification in a 
temporal and spatial manner are the protein-guided Transcription Activator-Like 
Effectors (TALEs) and the-RNA guided Clustered Regularly Interspaced Short 
Palindromic Repeats CRISPR/Cas9 systems 139. However, the direct manipulation of 
epigenetic marks will be challenging because of potential off target effects and 
epigenetic modifiers might be more useful in manipulating the epigenome towards 
an enhanced plasticity to enable the reversal of pathological marks by conventional 
techniques such as psychotherapy or medications 140. 
Apart from therapeutically targeting epigenetic marks, a profound knowledge on 
disease associated epigenetic imprints will be helpful in predicting and tracking 
therapeutic approaches 141-143.  
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